*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 5 1b6b_c00 ARYLALKYLAMINE N-ACETYLTRANSFERASE user 1 5 # 1 B 97 SER A 103 SER^? -4.23 C1 EDO A 163s B 111 LEU A 100 LEU^? 9.16 C2 EDO A 160 B 122 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 124 LEU A 61 LEU^? 15.04 O1 EDO A 159 B 168 TYR A 68 TYR^? 16.54 O2 EDO A 161 coo 22.13 1.08 47.05 23.48 1.32 45.04 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo 29.34 2.09 42.81 29.09 3.84 41.58 -7.88 26.52 -25.57 -7.13 28.27 -26.49 coo 21.52 -2.11 42.26 22.66 -0.38 42.71 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 12.75 -6.10 41.77 10.57 -5.92 42.03 -0.38 17.67 -9.30 1.00 19.33 -8.88 coo 8.38 -0.15 37.83 9.82 -2.52 38.13 0.78 23.48 -5.65 0.20 25.74 -7.17 1b6b_c00 source 1b6b ARYLALKYLAMINE N-ACETYLTRANSFERASE : 1 hits 1b6b_c00 naa= 5 ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 A 39 ARG A 139 ARG~? -3.63 O1 EDO A 162s A 219 LYS A 119 LYS^? 11.66 O2 EDO A 162 A 376 GLY A 138 GLY~? -3.61 C2 EDO A 161s A 399 GLY A 135 GLY^? 9.03 O2 EDO A 162 coo -12.38 76.96 90.60 -12.31 75.41 87.97 7.88 34.40 -21.89 8.75 37.33 -21.46 coo -15.03 67.62 79.35 -16.01 71.68 83.38 -5.14 35.78 -15.21 -3.31 32.89 -10.27 coo -9.88 73.08 89.49 -9.40 72.65 89.00 5.34 29.81 -22.27 4.79 30.34 -22.58 coo -11.12 75.93 79.79 -10.82 76.54 80.30 -0.79 26.83 -16.51 -1.09 27.58 -16.27 13pk_c00 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c00 naa= 4 ULMN 4 13pk_c01 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 B 39 ARG A 139 ARG~? -3.63 O1 EDO A 162s B 219 LYS A 119 LYS^? 11.66 O2 EDO A 162 B 376 GLY A 138 GLY~? -3.61 C2 EDO A 161s B 399 GLY A 135 GLY^? 9.03 O2 EDO A 162 coo -2.66 39.94 47.71 -4.08 39.67 44.99 7.88 34.40 -21.89 8.75 37.33 -21.46 coo -12.62 42.34 36.27 -8.73 43.54 40.31 -5.14 35.78 -15.21 -3.31 32.89 -10.27 coo -6.85 37.45 46.42 -7.20 36.92 45.92 5.34 29.81 -22.27 4.79 30.34 -22.58 coo -4.26 38.64 36.66 -3.61 38.69 37.17 -0.79 26.83 -16.51 -1.09 27.58 -16.27 13pk_c01 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c01 naa= 4 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 C 39 ARG A 139 ARG~? -3.63 O1 EDO A 162s C 219 LYS A 119 LYS^? 11.66 O2 EDO A 162 C 376 GLY A 138 GLY~? -3.61 C2 EDO A 161s C 399 GLY A 135 GLY^? 9.03 O2 EDO A 162 coo -3.47 26.80 67.67 -1.24 26.00 69.62 7.88 34.40 -21.89 8.75 37.33 -21.46 coo 5.22 26.79 80.32 0.48 26.84 77.06 -5.14 35.78 -15.21 -3.31 32.89 -10.27 coo 1.35 28.76 68.50 2.09 28.66 68.61 5.34 29.81 -22.27 4.79 30.34 -22.58 coo 2.85 20.10 73.72 2.25 20.01 73.15 -0.79 26.83 -16.51 -1.09 27.58 -16.27 13pk_c02 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c02 naa= 4 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 D 39 ARG A 139 ARG~? -3.63 O1 EDO A 162s D 219 LYS A 119 LYS^? 11.66 O2 EDO A 162 D 376 GLY A 138 GLY~? -3.61 C2 EDO A 161s D 399 GLY A 135 GLY^? 9.03 O2 EDO A 162 coo 0.59 75.69 110.95 1.51 77.84 112.93 7.88 34.40 -21.89 8.75 37.33 -21.46 coo 1.28 85.37 123.16 0.84 80.41 120.28 -5.14 35.78 -15.21 -3.31 32.89 -10.27 coo -1.06 80.88 111.45 -0.91 81.65 111.55 5.34 29.81 -22.27 4.79 30.34 -22.58 coo 7.52 81.86 116.81 7.49 81.18 116.34 -0.79 26.83 -16.51 -1.09 27.58 -16.27 13pk_c03 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c03 naa= 4 ULMN 4 1rne_c05 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 4 # 1 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s 35 SER A 124 SER~? -4.02 O2 EDO A 162s 75 TYR A 126 TYR^? 6.32 O2 EDO A 162 215 ASP A 122 ASP~? -11.82 O1 EDO A 162s coo 11.85 17.24 72.81 11.09 15.37 72.36 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 12.20 12.71 75.45 13.69 13.84 74.03 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 15.08 11.29 68.68 16.45 12.70 70.65 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 5.22 15.03 71.43 7.19 14.88 70.83 3.64 43.10 -13.91 2.17 44.18 -12.90 1rne_c05 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 1 hits 1rne_c05 naa= 4 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 40 LYS A 55 LYS~? 4.25 C2 EDO A 163 B 114 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 3.53 13.68 -16.08 1.21 12.50 -21.79 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -9.50 18.02 -23.12 -8.37 16.46 -23.94 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 1 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 110 HIS^? 8.51 C1 EDO A 163 E 40 LYS A 55 LYS~? 4.25 C2 EDO A 163 E 114 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 3.53 13.68 -16.08 1.21 12.50 -21.79 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -9.50 18.02 -23.12 -8.37 16.46 -23.94 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 1 hits 1a4y_c01 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 68 TYR^? 16.54 O2 EDO A 161 A 125 HIS A 62 HIS^? 12.35 O2 EDO A 159 A 156 LYS A 76 LYS^? -2.76 O2 EDO A 159s coo 37.11 -19.03 58.81 39.12 -18.07 60.48 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -0.73 12.68 0.50 -5.34 10.31 1.50 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 68 TYR^? 16.54 O2 EDO A 161 B 125 HIS A 62 HIS^? 12.35 O2 EDO A 159 B 156 LYS A 76 LYS^? -2.76 O2 EDO A 159s coo 52.78 -23.08 19.46 51.79 -21.72 17.22 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -0.73 12.68 0.50 -5.34 10.31 1.50 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 68 TYR^? 16.54 O2 EDO A 161 C 125 HIS A 62 HIS^? 12.35 O2 EDO A 159 C 156 LYS A 76 LYS^? -2.76 O2 EDO A 159s coo 72.53 -8.86 48.33 70.89 -10.65 46.92 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -0.73 12.68 0.50 -5.34 10.31 1.50 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 68 TYR^? 16.54 O2 EDO A 161 D 125 HIS A 62 HIS^? 12.35 O2 EDO A 159 D 156 LYS A 76 LYS^? -2.76 O2 EDO A 159s coo 54.10 1.42 85.16 54.14 4.17 85.62 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 61.27 5.43 85.32 62.73 6.38 86.49 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 60.28 4.62 76.00 58.35 6.41 80.65 -0.73 12.68 0.50 -5.34 10.31 1.50 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c03 naa= 3 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 1 3 # 1 44 LYS A 116 LYS~? 17.41 NA NA A 158 141 HIS A 62 HIS^? 12.35 O2 EDO A 159 333 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 69.56 26.03 31.04 72.53 30.39 31.84 -12.02 34.53 -20.62 -15.85 33.24 -18.37 coo 85.95 39.62 33.57 84.70 40.34 35.09 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 87.31 36.08 32.89 89.57 36.58 34.95 -6.19 16.74 -10.46 -4.80 16.75 -13.27 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 2 3 # 2 44 LYS A 119 LYS^? 11.66 O2 EDO A 162 141 HIS A 62 HIS^? 12.35 O2 EDO A 159 333 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 69.56 26.03 31.04 72.53 30.39 31.84 -5.14 35.78 -15.21 -3.31 32.89 -10.27 coo 85.95 39.62 33.57 84.70 40.34 35.09 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 87.31 36.08 32.89 89.57 36.58 34.95 -6.19 16.74 -10.46 -4.80 16.75 -13.27 1aa6_c01 source 1aa6 FORMATE DEHYDROGENASE H : 2 hits 1aa6_c01 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 131 ARG~? 12.47 C2 EDO A 163 78 HIS A 110 HIS^? 8.51 C1 EDO A 163 122 TYR A 143 TYR~? -3.94 O1 EDO A 165s coo 48.32 72.26 30.89 48.69 69.28 31.53 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo 53.63 68.24 34.99 53.08 69.10 33.16 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 75.01 61.87 32.93 75.34 59.26 31.96 4.43 37.29 -29.96 6.41 39.04 -28.97 1ab4_c00 source 1ab4 GYRASE A : 1 hits 1ab4_c00 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 104 THR^? 6.75 C1 EDO A 163 350 PHE A 91 PHE^? 3.94 C2 EDO A 160 357 CYH A 141 CYH~? -4.10 O1 EDO A 160s coo 17.85 20.47 14.62 16.85 19.84 12.80 2.38 21.48 -21.38 1.40 20.74 -19.63 coo 7.92 21.96 13.27 8.57 20.30 15.42 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo 8.82 20.77 7.90 10.59 19.75 9.80 3.42 30.61 -27.67 3.13 28.26 -26.13 1akd_c01 source 1akd CYTOCHROME P450CAM : 1 hits 1akd_c01 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 41 ASP.? 9.35 C1 EDO A 161 35 SER A 48 SER^? 16.22 C1 EDO A 161 215 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo -7.18 8.92 145.10 -8.77 8.81 143.59 12.12 21.63 -14.87 12.29 22.09 -16.92 coo -12.30 10.35 145.24 -10.75 8.55 145.88 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -8.20 12.64 138.30 -8.86 10.97 139.38 11.16 21.43 -6.03 11.57 21.49 -3.94 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s 35 SER A 124 SER~? -4.02 O2 EDO A 162s 215 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo -7.18 8.92 145.10 -8.77 8.81 143.59 6.11 38.48 -15.06 7.29 39.80 -13.91 coo -12.30 10.35 145.24 -10.75 8.55 145.88 3.00 36.38 -17.33 4.86 35.21 -16.28 coo -8.20 12.64 138.30 -8.86 10.97 139.38 6.13 30.51 -11.36 5.19 32.07 -12.37 1am5_c04 source 1am5 PEPSIN : 2 hits 1am5_c04 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 35 ASP^? -18.12 O1 EDO A 159s 214 ASP A 153 ASP~? 8.10 NA NA A 158 289 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo -0.62 65.95 29.97 0.31 67.47 31.05 11.16 21.43 -6.03 11.57 21.49 -3.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 -12.75 34.73 -26.28 -11.93 33.33 -27.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 6.13 30.51 -11.36 5.19 32.07 -12.37 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 83 ASP.? 7.90 O2 EDO A 161 204 GLU A 82 GLU.? 10.18 O2 EDO A 161 289 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo -0.62 65.95 29.97 0.31 67.47 31.05 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 4.34 62.44 32.05 4.22 64.48 32.53 9.87 29.84 -8.60 11.75 29.89 -9.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 11.16 21.43 -6.03 11.57 21.49 -3.94 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c05 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 41 ASP.? 9.35 C1 EDO A 161 E 36 SER A 48 SER^? 16.22 C1 EDO A 161 E 213 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 26.30 12.96 16.78 25.46 12.99 18.72 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 28.33 15.15 21.27 28.70 13.12 19.97 15.58 16.01 -11.89 15.60 16.65 -14.21 coo 20.15 16.04 19.79 21.65 14.49 19.86 11.16 21.43 -6.03 11.57 21.49 -3.94 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP A 123 ASP~? -8.02 O1 EDO A 162s E 36 SER A 124 SER~? -4.02 O2 EDO A 162s E 213 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 26.30 12.96 16.78 25.46 12.99 18.72 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 28.33 15.15 21.27 28.70 13.12 19.97 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 20.15 16.04 19.79 21.65 14.49 19.86 6.13 30.51 -11.36 5.19 32.07 -12.37 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 2 hits 1apt_c04 naa= 3 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 A 38 ARG A 93 ARG^? 7.83 NA NA A 158 A 42 HIS A 97 HIS.? 9.64 NA NA A 158 A 71 ASN A 150 ASN~? 5.62 NA NA A 158 coo 15.53 3.67 5.89 15.40 6.73 5.59 -10.69 28.80 -31.07 -11.04 31.37 -29.39 coo 20.65 4.50 6.93 19.74 4.89 5.08 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 19.78 9.98 8.03 21.51 8.73 8.26 -12.61 34.90 -31.27 -11.66 33.55 -32.64 1apx_c00 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 1 hits 1apx_c00 naa= 3 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 B 38 ARG A 93 ARG^? 7.83 NA NA A 158 B 42 HIS A 97 HIS.? 9.64 NA NA A 158 B 71 ASN A 150 ASN~? 5.62 NA NA A 158 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 -10.69 28.80 -31.07 -11.04 31.37 -29.39 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 -12.61 34.90 -31.27 -11.66 33.55 -32.64 1apx_c01 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 1 hits 1apx_c01 naa= 3 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 C 38 ARG A 93 ARG^? 7.83 NA NA A 158 C 42 HIS A 97 HIS.? 9.64 NA NA A 158 C 71 ASN A 150 ASN~? 5.62 NA NA A 158 coo 30.92 18.62 52.11 32.84 21.02 52.26 -10.69 28.80 -31.07 -11.04 31.37 -29.39 coo 34.83 15.89 54.93 35.12 16.59 52.97 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 37.12 20.79 56.54 37.65 18.79 57.02 -12.61 34.90 -31.27 -11.66 33.55 -32.64 1apx_c02 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 1 hits 1apx_c02 naa= 3 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 D 38 ARG A 93 ARG^? 7.83 NA NA A 158 D 42 HIS A 97 HIS.? 9.64 NA NA A 158 D 71 ASN A 150 ASN~? 5.62 NA NA A 158 coo -6.22 19.15 57.90 -8.28 20.35 55.95 -10.69 28.80 -31.07 -11.04 31.37 -29.39 coo -9.68 15.08 58.37 -9.88 17.07 58.99 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo -12.42 16.33 53.67 -12.99 14.86 55.12 -12.61 34.90 -31.27 -11.66 33.55 -32.64 1apx_c03 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 1 hits 1apx_c03 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s A 35 SER A 124 SER~? -4.02 O2 EDO A 162s A 217 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo -10.06 2.54 49.69 -8.83 3.73 50.96 6.11 38.48 -15.06 7.29 39.80 -13.91 coo -11.96 5.74 52.90 -10.55 6.74 51.22 3.00 36.38 -17.33 4.86 35.21 -16.28 coo -5.22 1.43 56.08 -5.36 2.84 54.49 6.13 30.51 -11.36 5.19 32.07 -12.37 1avf_c04 source 1avf GASTRICSIN : 1 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s J 35 SER A 124 SER~? -4.02 O2 EDO A 162s J 217 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 6.11 38.48 -15.06 7.29 39.80 -13.91 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 3.00 36.38 -17.33 4.86 35.21 -16.28 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 6.13 30.51 -11.36 5.19 32.07 -12.37 1avf_c05 source 1avf GASTRICSIN : 1 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 34 PHE^? 12.69 O1 EDO A 159 A 223 ASP A 41 ASP.? 9.35 C1 EDO A 161 A 265 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 39.74 52.86 65.74 41.15 55.14 66.52 7.43 15.53 -5.36 7.24 12.73 -5.43 coo 30.70 47.50 67.53 29.83 49.47 67.39 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 19.99 54.53 64.11 20.55 58.78 68.33 1.64 29.66 -17.31 7.12 31.17 -15.42 1ax4_c04 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 34 PHE^? 12.69 O1 EDO A 159 B 223 ASP A 41 ASP.? 9.35 C1 EDO A 161 B 265 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 7.48 54.94 99.62 7.67 52.27 100.42 7.43 15.53 -5.36 7.24 12.73 -5.43 coo 10.43 61.66 91.81 9.80 60.04 90.61 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 5.43 58.06 80.08 8.57 53.00 79.37 1.64 29.66 -17.31 7.12 31.17 -15.42 1ax4_c05 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 34 PHE^? 12.69 O1 EDO A 159 C 223 ASP A 41 ASP.? 9.35 C1 EDO A 161 C 265 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo -6.55 73.45 23.60 -6.77 71.48 21.66 7.43 15.53 -5.36 7.24 12.73 -5.43 coo -9.52 75.74 33.62 -8.85 73.74 33.93 12.12 21.63 -14.87 12.29 22.09 -16.92 coo -4.44 67.20 42.32 -7.50 62.41 40.49 1.64 29.66 -17.31 7.12 31.17 -15.42 1ax4_c06 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 34 PHE^? 12.69 O1 EDO A 159 D 223 ASP A 41 ASP.? 9.35 C1 EDO A 161 D 265 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo -38.60 55.38 52.70 -40.06 57.72 53.04 7.43 15.53 -5.36 7.24 12.73 -5.43 coo -29.46 51.67 48.51 -28.63 53.31 49.56 12.12 21.63 -14.87 12.29 22.09 -16.92 coo -18.87 56.53 54.79 -19.47 62.22 53.03 1.64 29.66 -17.31 7.12 31.17 -15.42 1ax4_c07 source 1ax4 TRYPTOPHANASE : 1 hits 1ax4_c07 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 58 GLU A 130 GLU~? 11.31 C2 EDO A 163 A 92 HIS A 62 HIS^? 12.35 O2 EDO A 159 coo 12.70 27.74 1.76 10.77 27.11 1.24 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 11.38 23.30 3.20 9.27 23.34 3.13 -7.35 18.96 -14.22 -6.42 19.01 -16.12 coo 2.67 19.36 1.56 3.51 21.24 1.94 -5.47 17.51 -6.29 -6.49 15.78 -6.92 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 1 hits 1b2m_c00 naa= 3 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 B 40 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 58 GLU A 130 GLU~? 11.31 C2 EDO A 163 B 92 HIS A 62 HIS^? 12.35 O2 EDO A 159 coo 10.74 36.24 16.20 9.81 34.52 16.97 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 5.02 36.40 17.74 5.55 34.41 17.37 -7.35 18.96 -14.22 -6.42 19.01 -16.12 coo 0.68 29.04 20.43 2.46 29.56 19.46 -5.47 17.51 -6.29 -6.49 15.78 -6.92 1b2m_c01 source 1b2m 5'-R(*GP*(CH2)U)-3' : 1 hits 1b2m_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 90 ASP^? -3.94 O2 EDO A 160s A 182 GLU A 92 GLU^? 8.42 O2 EDO A 160 A 286 ASN A 144 ASN~? -3.85 O1 EDO A 160s coo 26.03 44.66 108.90 25.67 42.61 108.82 1.27 23.34 -28.00 0.91 23.40 -30.08 coo 18.06 44.02 105.38 18.08 45.37 107.03 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo 25.47 38.28 112.06 27.26 39.30 111.54 0.74 31.64 -31.25 2.27 31.36 -32.72 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 1 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 90 ASP^? -3.94 O2 EDO A 160s B 182 GLU A 92 GLU^? 8.42 O2 EDO A 160 B 286 ASN A 144 ASN~? -3.85 O1 EDO A 160s coo 13.82 69.26 132.27 11.87 70.14 132.51 1.27 23.34 -28.00 0.91 23.40 -30.08 coo 8.74 63.05 136.42 9.87 62.19 134.79 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo 8.26 72.60 129.22 10.14 73.45 129.80 0.74 31.64 -31.25 2.27 31.36 -32.72 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 1 hits 1b57_c01 naa= 3 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 60 GLU A 92 GLU^? 8.42 O2 EDO A 160 A 148 CYH A 141 CYH~? -4.10 O1 EDO A 160s A 179 ASP A 90 ASP^? -3.94 O2 EDO A 160s coo 20.47 15.77 27.32 19.04 14.27 26.94 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo 21.87 3.71 21.27 20.32 3.55 23.64 3.42 30.61 -27.67 3.13 28.26 -26.13 coo 17.09 11.24 20.19 17.85 10.05 21.76 1.27 23.34 -28.00 0.91 23.40 -30.08 1b5d_c04 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 1 hits 1b5d_c04 naa= 3 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 60 GLU A 92 GLU^? 8.42 O2 EDO A 160 B 148 CYH A 141 CYH~? -4.10 O1 EDO A 160s B 179 ASP A 90 ASP^? -3.94 O2 EDO A 160s coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo 30.30 0.93 3.58 31.01 1.18 0.88 3.42 30.61 -27.67 3.13 28.26 -26.13 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 1.27 23.34 -28.00 0.91 23.40 -30.08 1b5d_c05 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 1 hits 1b5d_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 145 PHE~? 8.08 C2 EDO A 162 A 159 ASP A 90 ASP^? -3.94 O2 EDO A 160s A 188 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 13.91 34.58 14.67 12.95 36.00 12.47 -2.74 33.25 -25.54 -4.85 33.57 -23.76 coo 20.97 28.40 16.26 20.19 30.15 15.34 1.27 23.34 -28.00 0.91 23.40 -30.08 coo 22.55 41.65 15.60 18.92 37.20 14.63 1.64 29.66 -17.31 7.12 31.17 -15.42 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 145 PHE~? 8.08 C2 EDO A 162 A 159 ASP A 153 ASP~? 8.10 NA NA A 158 A 188 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 13.91 34.58 14.67 12.95 36.00 12.47 -2.74 33.25 -25.54 -4.85 33.57 -23.76 coo 20.97 28.40 16.26 20.19 30.15 15.34 -12.75 34.73 -26.28 -11.93 33.33 -27.60 coo 22.55 41.65 15.60 18.92 37.20 14.63 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 2 hits 1b9h_c02 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s 35 SER A 124 SER~? -4.02 O2 EDO A 162s 215 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 61.19 45.85 78.73 62.86 45.48 77.48 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 66.00 46.17 80.29 64.31 47.92 79.91 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 63.61 40.10 74.06 64.05 42.07 74.70 6.13 30.51 -11.36 5.19 32.07 -12.37 1bbs_c06 source 1bbs RENIN : 1 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s 35 SER A 124 SER~? -4.02 O2 EDO A 162s 215 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 61.19 45.85 78.73 62.86 45.48 77.48 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 66.00 46.17 80.29 64.31 47.92 79.91 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 63.61 40.10 74.06 64.05 42.07 74.70 6.13 30.51 -11.36 5.19 32.07 -12.37 1bbs_c07 source 1bbs RENIN : 1 hits 1bbs_c07 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 131 ARG~? 12.47 C2 EDO A 163 C 141 THR A 72 THR.? 7.55 C2 EDO A 159 C 235 ASP A 66 ASP.? 19.80 O2 EDO A 162 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -3.45 9.25 -3.33 -1.45 8.50 -3.70 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -2.90 29.23 -2.02 -4.63 30.38 -2.07 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 83 ASP.? 7.90 O2 EDO A 161 435 GLU A 82 GLU.? 10.18 O2 EDO A 161 510 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 88.62 69.90 41.16 89.05 70.67 43.04 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 89.52 76.11 40.17 89.01 75.16 41.97 9.87 29.84 -8.60 11.75 29.89 -9.60 coo 84.89 77.60 46.67 85.63 75.79 46.03 11.16 21.43 -6.03 11.57 21.49 -3.94 1bf2_c00 source 1bf2 ISOAMYLASE : 1 hits 1bf2_c00 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 93 ARG^? 7.83 NA NA A 158 183 LYS A 116 LYS~? 17.41 NA NA A 158 317 ARG A 139 ARG~? -3.63 O1 EDO A 162s coo 76.57 109.19 73.41 73.86 110.26 72.16 -10.69 28.80 -31.07 -11.04 31.37 -29.39 coo 82.09 117.51 66.37 80.60 114.32 71.44 -12.02 34.53 -20.62 -15.85 33.24 -18.37 coo 65.21 120.62 58.76 63.62 123.14 59.66 7.88 34.40 -21.89 8.75 37.33 -21.46 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 1 hits 1bib_c00 naa= 3 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 1 3 # 1 A 102 TRP A 42 TRP^? 14.27 C1 EDO A 163 A 174 ASP A 41 ASP.? 9.35 C1 EDO A 161 A 198 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 21.59 67.76 35.19 19.10 64.95 36.34 7.37 19.00 -12.95 4.75 17.31 -10.59 coo 19.39 73.14 39.98 19.70 71.07 40.14 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 27.94 65.10 43.55 24.20 64.94 40.01 7.21 11.23 -18.19 10.21 5.87 -19.86 1bjo_c00 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 1 hits 1bjo_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 93 ARG^? 7.83 NA NA A 158 A 128 GLU A 92 GLU^? 8.42 O2 EDO A 160 A 225 GLU A 148 GLU~? 6.95 NA NA A 158 coo 38.56 19.11 14.83 37.12 21.00 16.76 -10.69 28.80 -31.07 -11.04 31.37 -29.39 coo 36.48 24.43 22.02 36.86 26.34 21.13 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo 40.16 23.71 17.01 38.52 24.96 17.40 -6.53 31.30 -30.27 -6.73 30.41 -32.19 1bqc_c01 source 1bqc BETA-MANNANASE : 1 hits 1bqc_c01 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 104 THR^? 6.75 C1 EDO A 163 A 393 PHE A 91 PHE^? 3.94 C2 EDO A 160 A 400 CYH A 141 CYH~? -4.10 O1 EDO A 160s coo 45.81 71.19 43.26 47.70 70.19 43.25 2.38 21.48 -21.38 1.40 20.74 -19.63 coo 48.54 63.17 48.16 46.74 64.99 49.22 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo 53.76 64.39 46.87 52.06 66.55 47.33 3.42 30.61 -27.67 3.13 28.26 -26.13 1bu7_c02 source 1bu7 CYTOCHROME P450 : 1 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 104 THR^? 6.75 C1 EDO A 163 B 393 PHE A 91 PHE^? 3.94 C2 EDO A 160 B 400 CYH A 141 CYH~? -4.10 O1 EDO A 160s coo 37.20 116.32 52.00 35.18 117.07 52.13 2.38 21.48 -21.38 1.40 20.74 -19.63 coo 33.81 121.65 59.26 35.49 119.55 59.81 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo 28.79 121.15 57.00 30.51 118.99 56.70 3.42 30.61 -27.67 3.13 28.26 -26.13 1bu7_c03 source 1bu7 CYTOCHROME P450 : 1 hits 1bu7_c03 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 354 GLU A 82 GLU.? 10.18 O2 EDO A 161 A 421 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 31.05 49.37 64.51 31.97 51.11 63.85 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 29.07 50.42 58.36 29.02 52.18 59.49 9.87 29.84 -8.60 11.75 29.89 -9.60 coo 30.82 59.76 58.47 31.12 59.02 60.40 11.16 21.43 -6.03 11.57 21.49 -3.94 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 354 GLU A 82 GLU.? 10.18 O2 EDO A 161 A 421 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 31.05 49.37 64.51 31.97 51.11 63.85 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 29.07 50.42 58.36 29.02 52.18 59.49 9.87 29.84 -8.60 11.75 29.89 -9.60 coo 30.82 59.76 58.47 31.12 59.02 60.40 12.12 21.63 -14.87 12.29 22.09 -16.92 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c08 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 41 ASP.? 9.35 C1 EDO A 161 264 GLU A 30 GLU.? 9.09 O1 EDO A 159 328 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 45.62 80.42 43.69 45.65 82.01 45.07 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 59.69 92.71 39.85 58.53 92.03 41.47 5.78 17.17 4.62 5.27 17.35 2.55 coo 45.39 90.72 40.63 45.07 89.14 41.90 11.16 21.43 -6.03 11.57 21.49 -3.94 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 41 ASP.? 9.35 C1 EDO A 161 264 GLU A 67 GLU^? 14.56 O1 EDO A 159 328 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 45.62 80.42 43.69 45.65 82.01 45.07 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 59.69 92.71 39.85 58.53 92.03 41.47 -0.83 25.67 0.86 -1.19 25.22 2.93 coo 45.39 90.72 40.63 45.07 89.14 41.90 11.16 21.43 -6.03 11.57 21.49 -3.94 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 41 ASP.? 9.35 C1 EDO A 161 264 GLU A 67 GLU^? 14.56 O1 EDO A 159 328 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 45.62 80.42 43.69 45.65 82.01 45.07 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 59.69 92.71 39.85 58.53 92.03 41.47 -0.83 25.67 0.86 -1.19 25.22 2.93 coo 45.39 90.72 40.63 45.07 89.14 41.90 6.13 30.51 -11.36 5.19 32.07 -12.37 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 83 ASP.? 7.90 O2 EDO A 161 264 GLU A 30 GLU.? 9.09 O1 EDO A 159 328 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 45.62 80.42 43.69 45.65 82.01 45.07 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 59.69 92.71 39.85 58.53 92.03 41.47 5.78 17.17 4.62 5.27 17.35 2.55 coo 45.39 90.72 40.63 45.07 89.14 41.90 11.16 21.43 -6.03 11.57 21.49 -3.94 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 4 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 46 GLY.? 20.81 O2 EDO A 161 A 228 SER A 48 SER^? 16.22 C1 EDO A 161 A 549 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 16.73 17.44 -5.47 16.44 16.80 -5.81 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 15.58 16.01 -11.89 15.60 16.65 -14.21 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 12.12 21.63 -14.87 12.29 22.09 -16.92 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 107 GLY.? -3.73 O1 EDO A 163s A 228 SER A 103 SER^? -4.23 C1 EDO A 163s A 549 ASP A 90 ASP^? -3.94 O2 EDO A 160s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 3.39 16.45 -21.94 3.10 16.75 -21.28 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 1.27 23.34 -28.00 0.91 23.40 -30.08 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY A 138 GLY~? -3.61 C2 EDO A 161s A 228 SER A 124 SER~? -4.02 O2 EDO A 162s A 549 ASP A 123 ASP~? -8.02 O1 EDO A 162s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 5.34 29.81 -22.27 4.79 30.34 -22.58 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 6.11 38.48 -15.06 7.29 39.80 -13.91 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 3 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 46 GLY.? 20.81 O2 EDO A 161 B1228 SER A 48 SER^? 16.22 C1 EDO A 161 B1549 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 126.34 72.75 125.66 125.95 73.27 126.11 16.73 17.44 -5.47 16.44 16.80 -5.81 coo 131.65 74.68 129.41 130.31 72.73 128.82 15.58 16.01 -11.89 15.60 16.65 -14.21 coo 134.72 69.43 130.42 133.03 70.65 130.08 12.12 21.63 -14.87 12.29 22.09 -16.92 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 107 GLY.? -3.73 O1 EDO A 163s B1228 SER A 103 SER^? -4.23 C1 EDO A 163s B1549 ASP A 90 ASP^? -3.94 O2 EDO A 160s coo 126.34 72.75 125.66 125.95 73.27 126.11 3.39 16.45 -21.94 3.10 16.75 -21.28 coo 131.65 74.68 129.41 130.31 72.73 128.82 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo 134.72 69.43 130.42 133.03 70.65 130.08 1.27 23.34 -28.00 0.91 23.40 -30.08 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY A 138 GLY~? -3.61 C2 EDO A 161s B1228 SER A 124 SER~? -4.02 O2 EDO A 162s B1549 ASP A 123 ASP~? -8.02 O1 EDO A 162s coo 126.34 72.75 125.66 125.95 73.27 126.11 5.34 29.81 -22.27 4.79 30.34 -22.58 coo 131.65 74.68 129.41 130.31 72.73 128.82 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 134.72 69.43 130.42 133.03 70.65 130.08 6.11 38.48 -15.06 7.29 39.80 -13.91 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 3 hits 1cjy_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 123 ASP~? -8.02 O1 EDO A 162s 37 SER A 124 SER~? -4.02 O2 EDO A 162s 216 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 16.90 26.20 29.49 16.22 24.50 28.41 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 12.23 24.31 30.40 14.55 23.96 31.03 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 13.93 25.52 22.10 14.75 24.44 23.75 6.13 30.51 -11.36 5.19 32.07 -12.37 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 1 hits 1cms_c04 naa= 3 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 3 # 1 361 GLU A 92 GLU^? 8.42 O2 EDO A 160 447 HIS A 111 HIS^? 8.62 O2 EDO A 163 485 ASN A 101 ASN^? 9.58 O2 EDO A 163 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -9.50 18.02 -23.12 -8.37 16.46 -23.94 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -7.00 21.19 -26.68 -8.88 20.25 -27.01 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 2 3 # 2 361 GLU A 130 GLU~? 11.31 C2 EDO A 163 447 HIS A 111 HIS^? 8.62 O2 EDO A 163 485 ASN A 112 ASN^? 14.73 O2 EDO A 163 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -7.35 18.96 -14.22 -6.42 19.01 -16.12 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -9.50 18.02 -23.12 -8.37 16.46 -23.94 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -13.14 22.32 -21.21 -14.04 20.67 -22.19 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 3 3 # 3 361 GLU A 148 GLU~? 6.95 NA NA A 158 447 HIS A 97 HIS.? 9.64 NA NA A 158 485 ASN A 150 ASN~? 5.62 NA NA A 158 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -6.53 31.30 -30.27 -6.73 30.41 -32.19 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -12.61 34.90 -31.27 -11.66 33.55 -32.64 1coy_c00 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 3 hits 1coy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 68 TYR^? 16.54 O2 EDO A 161 A 173 ASP A 66 ASP.? 19.80 O2 EDO A 162 C 48 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 24.35 4.55 25.11 25.94 3.23 25.53 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -6.19 16.74 -10.46 -4.80 16.75 -13.27 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 131 ARG~? 12.47 C2 EDO A 163 C 101 TYR A 68 TYR^? 16.54 O2 EDO A 161 C 173 ASP A 66 ASP.? 19.80 O2 EDO A 162 coo 32.27 5.62 48.15 31.93 6.48 51.06 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo 29.64 3.64 57.39 31.22 5.14 55.65 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -2.90 29.23 -2.02 -4.63 30.38 -2.07 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 78 ARG^? 11.61 O1 EDO A 159 D 101 TYR A 68 TYR^? 16.54 O2 EDO A 161 D 173 ASP A 66 ASP.? 19.80 O2 EDO A 162 coo 69.08 8.58 32.60 69.70 10.81 30.58 3.40 20.49 2.82 1.01 22.14 3.95 coo 71.77 11.86 24.26 70.23 12.22 26.56 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 71.60 6.14 19.25 70.26 6.87 20.69 -2.90 29.23 -2.02 -4.63 30.38 -2.07 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG A 131 ARG~? 12.47 C2 EDO A 163 D 101 TYR A 68 TYR^? 16.54 O2 EDO A 161 D 173 ASP A 66 ASP.? 19.80 O2 EDO A 162 coo 69.08 8.58 32.60 69.70 10.81 30.58 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo 71.77 11.86 24.26 70.23 12.22 26.56 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 71.60 6.14 19.25 70.26 6.87 20.69 -2.90 29.23 -2.02 -4.63 30.38 -2.07 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 68 TYR^? 16.54 O2 EDO A 161 B 173 ASP A 66 ASP.? 19.80 O2 EDO A 162 D 48 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -6.19 16.74 -10.46 -4.80 16.75 -13.27 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 83 ASP.? 7.90 O2 EDO A 161 315 GLU A 82 GLU.? 10.18 O2 EDO A 161 390 TYR A 68 TYR^? 16.54 O2 EDO A 161 coo 32.46 99.13 19.34 30.94 100.38 20.07 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 32.04 94.22 18.23 30.57 94.75 16.88 9.87 29.84 -8.60 11.75 29.89 -9.60 coo 21.10 94.74 18.36 23.09 96.71 18.59 0.78 23.48 -5.65 0.20 25.74 -7.17 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 1 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 340 GLU A 82 GLU.? 10.18 O2 EDO A 161 A 395 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 6.13 30.51 -11.36 5.19 32.07 -12.37 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 9.87 29.84 -8.60 11.75 29.89 -9.60 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 11.16 21.43 -6.03 11.57 21.49 -3.94 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 340 GLU A 82 GLU.? 10.18 O2 EDO A 161 A 395 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 6.13 30.51 -11.36 5.19 32.07 -12.37 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 9.87 29.84 -8.60 11.75 29.89 -9.60 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 12.12 21.63 -14.87 12.29 22.09 -16.92 1cwy_c00 source 1cwy AMYLOMALTASE : 2 hits 1cwy_c00 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 143 TYR~? -3.94 O1 EDO A 165s A 243 ASP A 41 ASP.? 9.35 C1 EDO A 161 A 272 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 2.03 68.31 21.46 0.66 68.36 23.90 4.43 37.29 -29.96 6.41 39.04 -28.97 coo 16.93 55.67 9.65 17.16 54.23 11.19 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 14.13 45.79 13.40 14.25 49.41 18.30 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 143 TYR~? -3.94 O1 EDO A 165s A 243 ASP A 41 ASP.? 9.35 C1 EDO A 161 A 272 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo 2.03 68.31 21.46 0.66 68.36 23.90 4.43 37.29 -29.96 6.41 39.04 -28.97 coo 16.93 55.67 9.65 17.16 54.23 11.19 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 14.13 45.79 13.40 14.25 49.41 18.30 3.53 13.68 -16.08 1.21 12.50 -21.79 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 2 hits 1d7r_c02 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 121 THR~? 7.82 O2 EDO A 162 A 156 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 160 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 10.50 56.87 17.73 11.24 57.93 19.43 0.49 39.42 -13.60 1.55 37.66 -13.04 coo 11.64 63.07 23.95 11.76 62.47 21.20 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 5.78 61.30 21.65 8.04 62.89 17.54 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 1 hits 1db3_c01 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 96 GLU A 130 GLU~? 11.31 C2 EDO A 163 A 137 HIS A 62 HIS^? 12.35 O2 EDO A 159 coo 1.83 2.95 4.76 1.26 0.98 4.81 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -7.35 18.96 -14.22 -6.42 19.01 -16.12 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -5.47 17.51 -6.29 -6.49 15.78 -6.92 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 1 hits 1de3_c00 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 43 THR^? 16.73 O2 EDO A 161 A 45 THR A 47 THR^? 22.44 O1 EDO A 159 A 161 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 26.16 88.25 79.16 25.22 89.47 80.71 12.68 17.56 -8.98 14.04 19.15 -8.51 coo 27.73 89.90 76.08 29.24 91.46 75.95 17.01 15.09 -8.48 17.85 13.06 -8.55 coo 33.83 91.15 88.62 31.07 91.06 83.02 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 43 THR^? 16.73 O2 EDO A 161 A 45 THR A 47 THR^? 22.44 O1 EDO A 159 A 161 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo 26.16 88.25 79.16 25.22 89.47 80.71 12.68 17.56 -8.98 14.04 19.15 -8.51 coo 27.73 89.90 76.08 29.24 91.46 75.95 17.01 15.09 -8.48 17.85 13.06 -8.55 coo 33.83 91.15 88.62 31.07 91.06 83.02 3.53 13.68 -16.08 1.21 12.50 -21.79 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR A 47 THR^? 22.44 O1 EDO A 159 A 45 THR A 43 THR^? 16.73 O2 EDO A 161 A 161 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 26.16 88.25 79.16 25.22 89.47 80.71 17.01 15.09 -8.48 17.85 13.06 -8.55 coo 27.73 89.90 76.08 29.24 91.46 75.95 12.68 17.56 -8.98 14.04 19.15 -8.51 coo 33.83 91.15 88.62 31.07 91.06 83.02 7.21 11.23 -18.19 10.21 5.87 -19.86 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 43 THR^? 16.73 O2 EDO A 161 B 45 THR A 47 THR^? 22.44 O1 EDO A 159 B 161 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 7.39 128.28 94.56 8.34 126.36 94.79 12.68 17.56 -8.98 14.04 19.15 -8.51 coo 5.75 129.25 91.25 4.29 128.16 90.07 17.01 15.09 -8.48 17.85 13.06 -8.55 coo -0.17 119.75 99.65 2.51 123.83 95.70 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 43 THR^? 16.73 O2 EDO A 161 B 45 THR A 47 THR^? 22.44 O1 EDO A 159 B 161 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo 7.39 128.28 94.56 8.34 126.36 94.79 12.68 17.56 -8.98 14.04 19.15 -8.51 coo 5.75 129.25 91.25 4.29 128.16 90.07 17.01 15.09 -8.48 17.85 13.06 -8.55 coo -0.17 119.75 99.65 2.51 123.83 95.70 3.53 13.68 -16.08 1.21 12.50 -21.79 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR A 47 THR^? 22.44 O1 EDO A 159 B 45 THR A 43 THR^? 16.73 O2 EDO A 161 B 161 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 7.39 128.28 94.56 8.34 126.36 94.79 17.01 15.09 -8.48 17.85 13.06 -8.55 coo 5.75 129.25 91.25 4.29 128.16 90.07 12.68 17.56 -8.98 14.04 19.15 -8.51 coo -0.17 119.75 99.65 2.51 123.83 95.70 7.21 11.23 -18.19 10.21 5.87 -19.86 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c03 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 44 TYR^? 14.32 O1 EDO A 159 A 40 ASP A 41 ASP.? 9.35 C1 EDO A 161 A 103 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 11.26 12.68 -5.54 10.51 10.98 -3.44 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 11.16 21.43 -6.03 11.57 21.49 -3.94 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 1 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 44 TYR^? 14.32 O1 EDO A 159 B 40 ASP A 41 ASP.? 9.35 C1 EDO A 161 B 103 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 11.26 12.68 -5.54 10.51 10.98 -3.44 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 11.16 21.43 -6.03 11.57 21.49 -3.94 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 1 hits 1e3v_c03 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 84 ALA.? 8.97 O2 EDO A 162 A 136 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 140 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 55.90 7.49 23.83 56.71 8.23 22.76 2.76 27.88 -11.85 2.16 28.28 -13.17 coo 59.38 10.02 17.51 59.95 9.89 20.21 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 59.52 3.69 18.67 62.31 6.19 22.58 1.64 29.66 -17.31 7.12 31.17 -15.42 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 1 hits 1e7q_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s A 35 SER A 124 SER~? -4.02 O2 EDO A 162s A 218 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 47.22 22.34 8.57 45.16 22.02 9.13 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 43.58 20.85 5.15 44.62 23.01 5.76 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 44.05 16.99 12.67 44.05 18.89 11.74 6.13 30.51 -11.36 5.19 32.07 -12.37 1eag_c04 source 1eag PEPTIDE INHIBITOR : 1 hits 1eag_c04 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 41 ASP.? 9.35 C1 EDO A 161 P 35 SER A 48 SER^? 16.22 C1 EDO A 161 P 215 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 10.15 33.41 11.98 7.98 33.66 12.07 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 7.57 37.60 10.00 8.86 37.02 12.03 15.58 16.01 -11.89 15.60 16.65 -14.21 coo 4.04 29.97 8.82 4.78 31.15 10.46 11.16 21.43 -6.03 11.57 21.49 -3.94 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s P 35 SER A 124 SER~? -4.02 O2 EDO A 162s P 215 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 10.15 33.41 11.98 7.98 33.66 12.07 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 7.57 37.60 10.00 8.86 37.02 12.03 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 4.04 29.97 8.82 4.78 31.15 10.46 6.13 30.51 -11.36 5.19 32.07 -12.37 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 2 hits 1eed_c04 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 51 ALA~? 9.13 O1 EDO A 163 A 257 ALA A 54 ALA~? 12.01 O1 EDO A 163 A 328 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 39.84 24.12 8.44 38.50 24.23 9.11 9.12 14.53 -18.25 9.05 15.02 -19.73 coo 43.22 26.73 5.37 41.81 27.09 5.79 6.61 14.57 -13.95 7.21 15.79 -14.59 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.12 21.63 -14.87 12.29 22.09 -16.92 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 54 ALA~? 12.01 O1 EDO A 163 A 257 ALA A 51 ALA~? 9.13 O1 EDO A 163 A 328 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 39.84 24.12 8.44 38.50 24.23 9.11 6.61 14.57 -13.95 7.21 15.79 -14.59 coo 43.22 26.73 5.37 41.81 27.09 5.79 9.12 14.53 -18.25 9.05 15.02 -19.73 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.12 21.63 -14.87 12.29 22.09 -16.92 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 84 ALA.? 8.97 O2 EDO A 162 A 257 ALA A 38 ALA.? 6.93 O2 EDO A 161 A 328 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 39.84 24.12 8.44 38.50 24.23 9.11 2.76 27.88 -11.85 2.16 28.28 -13.17 coo 43.22 26.73 5.37 41.81 27.09 5.79 9.44 28.61 -12.65 10.10 29.98 -12.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 11.16 21.43 -6.03 11.57 21.49 -3.94 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 84 ALA.? 8.97 O2 EDO A 162 A 257 ALA A 38 ALA.? 6.93 O2 EDO A 161 A 328 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 39.84 24.12 8.44 38.50 24.23 9.11 2.76 27.88 -11.85 2.16 28.28 -13.17 coo 43.22 26.73 5.37 41.81 27.09 5.79 9.44 28.61 -12.65 10.10 29.98 -12.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.12 21.63 -14.87 12.29 22.09 -16.92 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 84 ALA.? 8.97 O2 EDO A 162 A 257 ALA A 38 ALA.? 6.93 O2 EDO A 161 A 328 ASP A 123 ASP~? -8.02 O1 EDO A 162s coo 39.84 24.12 8.44 38.50 24.23 9.11 2.76 27.88 -11.85 2.16 28.28 -13.17 coo 43.22 26.73 5.37 41.81 27.09 5.79 9.44 28.61 -12.65 10.10 29.98 -12.53 coo 38.17 34.10 6.67 37.72 32.06 6.84 6.11 38.48 -15.06 7.29 39.80 -13.91 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 5 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 124 SER~? -4.02 O2 EDO A 162s A 140 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 144 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 34.67 35.79 48.83 33.57 37.88 49.47 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 29.60 38.99 53.89 30.10 37.88 51.36 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 32.73 32.94 54.42 29.29 32.83 50.35 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 124 SER~? -4.02 O2 EDO A 162s B 140 TYR A 126 TYR^? 6.32 O2 EDO A 162 B 144 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 30.90 35.65 89.60 29.85 37.72 88.83 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 24.43 38.83 86.53 27.07 38.03 86.12 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 25.13 32.62 89.49 27.74 32.61 84.91 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 124 SER~? -4.02 O2 EDO A 162s C 140 TYR A 126 TYR^? 6.32 O2 EDO A 162 C 144 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -8.96 33.70 98.81 -8.96 35.77 97.56 3.00 36.38 -17.33 4.86 35.21 -16.28 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 124 SER~? -4.02 O2 EDO A 162s D 140 TYR A 126 TYR^? 6.32 O2 EDO A 162 D 144 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -29.80 31.30 63.54 -28.79 33.52 63.37 3.00 36.38 -17.33 4.86 35.21 -16.28 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 124 SER~? -4.02 O2 EDO A 162s E 140 TYR A 126 TYR^? 6.32 O2 EDO A 162 E 144 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -3.01 32.72 32.71 -2.80 34.91 33.79 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 124 SER~? -4.02 O2 EDO A 162s F 140 TYR A 126 TYR^? 6.32 O2 EDO A 162 F 144 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 55.30 92.46 56.72 55.15 90.39 55.38 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 54.49 89.31 49.65 53.35 90.16 52.06 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 56.78 95.62 51.15 51.59 95.31 52.37 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 124 SER~? -4.02 O2 EDO A 162s G 140 TYR A 126 TYR^? 6.32 O2 EDO A 162 G 144 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 76.25 95.63 21.56 75.29 93.40 21.36 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 69.78 91.62 20.06 71.51 92.68 22.02 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 71.19 98.21 18.32 70.69 97.75 23.67 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 124 SER~? -4.02 O2 EDO A 162s H 140 TYR A 126 TYR^? 6.32 O2 EDO A 162 H 144 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 15.45 90.62 47.70 16.55 88.57 46.97 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 21.92 87.58 44.67 19.30 88.41 44.23 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 21.26 93.70 47.67 18.47 93.68 43.08 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 124 SER~? -4.02 O2 EDO A 162s I 140 TYR A 126 TYR^? 6.32 O2 EDO A 162 I 144 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 11.78 90.82 7.18 12.84 88.72 7.93 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 16.78 87.76 12.19 16.39 88.69 9.59 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 13.67 93.83 12.65 17.08 93.94 8.58 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 124 SER~? -4.02 O2 EDO A 162s J 140 TYR A 126 TYR^? 6.32 O2 EDO A 162 J 144 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 104 THR^? 6.75 C1 EDO A 163 A 159 LYS A 136 LYS^? 4.23 O2 EDO A 161 A 193 GLU A 82 GLU.? 10.18 O2 EDO A 161 coo -2.58 16.31 54.79 -4.02 14.93 55.64 2.38 21.48 -21.38 1.40 20.74 -19.63 coo 2.10 10.68 61.44 -2.14 13.16 60.61 1.64 29.66 -17.31 7.12 31.17 -15.42 coo -5.33 11.71 69.72 -4.62 11.92 67.73 9.87 29.84 -8.60 11.75 29.89 -9.60 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 121 THR~? 7.82 O2 EDO A 162 A 159 LYS A 136 LYS^? 4.23 O2 EDO A 161 A 193 GLU A 82 GLU.? 10.18 O2 EDO A 161 coo -2.58 16.31 54.79 -4.02 14.93 55.64 0.49 39.42 -13.60 1.55 37.66 -13.04 coo 2.10 10.68 61.44 -2.14 13.16 60.61 1.64 29.66 -17.31 7.12 31.17 -15.42 coo -5.33 11.71 69.72 -4.62 11.92 67.73 9.87 29.84 -8.60 11.75 29.89 -9.60 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c02 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 34 PHE^? 12.69 O1 EDO A 159 A 210 ASP A 41 ASP.? 9.35 C1 EDO A 161 A 244 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 9.23 46.77 25.11 11.48 48.39 24.76 7.43 15.53 -5.36 7.24 12.73 -5.43 coo 10.51 37.86 19.71 9.07 39.38 20.04 12.12 21.63 -14.87 12.29 22.09 -16.92 coo -1.20 42.34 17.67 3.19 45.13 19.06 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 91 PHE^? 3.94 C2 EDO A 160 A 210 ASP A 114 ASP~? 15.42 NA NA A 158 A 244 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 9.23 46.77 25.11 11.48 48.39 24.76 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo 10.51 37.86 19.71 9.07 39.38 20.04 -12.51 29.33 -20.19 -13.93 30.81 -20.67 coo -1.20 42.34 17.67 3.19 45.13 19.06 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 91 PHE^? 3.94 C2 EDO A 160 A 210 ASP A 153 ASP~? 8.10 NA NA A 158 A 244 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 9.23 46.77 25.11 11.48 48.39 24.76 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo 10.51 37.86 19.71 9.07 39.38 20.04 -12.75 34.73 -26.28 -11.93 33.33 -27.60 coo -1.20 42.34 17.67 3.19 45.13 19.06 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 149 PHE~? -6.17 NA NA A 158s A 210 ASP A 114 ASP~? 15.42 NA NA A 158 A 244 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 9.23 46.77 25.11 11.48 48.39 24.76 -9.07 38.04 -28.24 -11.22 39.46 -27.22 coo 10.51 37.86 19.71 9.07 39.38 20.04 -12.51 29.33 -20.19 -13.93 30.81 -20.67 coo -1.20 42.34 17.67 3.19 45.13 19.06 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 4 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 34 PHE^? 12.69 O1 EDO A 159 B 210 ASP A 41 ASP.? 9.35 C1 EDO A 161 B 244 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 8.76 47.85 34.91 11.08 46.36 35.41 7.43 15.53 -5.36 7.24 12.73 -5.43 coo 9.06 56.85 40.30 7.71 55.27 39.90 12.12 21.63 -14.87 12.29 22.09 -16.92 coo -2.38 51.82 41.62 2.07 49.19 40.42 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 91 PHE^? 3.94 C2 EDO A 160 B 210 ASP A 114 ASP~? 15.42 NA NA A 158 B 244 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 8.76 47.85 34.91 11.08 46.36 35.41 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo 9.06 56.85 40.30 7.71 55.27 39.90 -12.51 29.33 -20.19 -13.93 30.81 -20.67 coo -2.38 51.82 41.62 2.07 49.19 40.42 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 91 PHE^? 3.94 C2 EDO A 160 B 210 ASP A 153 ASP~? 8.10 NA NA A 158 B 244 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 8.76 47.85 34.91 11.08 46.36 35.41 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo 9.06 56.85 40.30 7.71 55.27 39.90 -12.75 34.73 -26.28 -11.93 33.33 -27.60 coo -2.38 51.82 41.62 2.07 49.19 40.42 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 149 PHE~? -6.17 NA NA A 158s B 210 ASP A 114 ASP~? 15.42 NA NA A 158 B 244 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 8.76 47.85 34.91 11.08 46.36 35.41 -9.07 38.04 -28.24 -11.22 39.46 -27.22 coo 9.06 56.85 40.30 7.71 55.27 39.90 -12.51 29.33 -20.19 -13.93 30.81 -20.67 coo -2.38 51.82 41.62 2.07 49.19 40.42 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 4 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 142 LEU A 86 LEU^? 10.77 C1 EDO A 163 A 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 1.18 23.08 -15.82 0.57 21.02 -15.41 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 142 LEU A 129 LEU~? 12.24 C1 EDO A 163 A 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -5.50 23.42 -15.88 -4.09 24.09 -17.42 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 142 LEU A 133 LEU~? 15.02 C1 EDO A 163 A 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -3.42 22.85 -11.94 -2.59 21.12 -10.84 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 B 142 LEU A 86 LEU^? 10.77 C1 EDO A 163 B 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 1.18 23.08 -15.82 0.57 21.02 -15.41 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 B 142 LEU A 129 LEU~? 12.24 C1 EDO A 163 B 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -5.50 23.42 -15.88 -4.09 24.09 -17.42 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 B 142 LEU A 133 LEU~? 15.02 C1 EDO A 163 B 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -3.42 22.85 -11.94 -2.59 21.12 -10.84 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 C 142 LEU A 86 LEU^? 10.77 C1 EDO A 163 C 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 1.18 23.08 -15.82 0.57 21.02 -15.41 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 C 142 LEU A 129 LEU~? 12.24 C1 EDO A 163 C 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -5.50 23.42 -15.88 -4.09 24.09 -17.42 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 C 142 LEU A 133 LEU~? 15.02 C1 EDO A 163 C 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -3.42 22.85 -11.94 -2.59 21.12 -10.84 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 D 142 LEU A 86 LEU^? 10.77 C1 EDO A 163 D 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 1.18 23.08 -15.82 0.57 21.02 -15.41 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 D 142 LEU A 129 LEU~? 12.24 C1 EDO A 163 D 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -5.50 23.42 -15.88 -4.09 24.09 -17.42 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 126 TYR^? 6.32 O2 EDO A 162 D 142 LEU A 133 LEU~? 15.02 C1 EDO A 163 D 165 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -3.42 22.85 -11.94 -2.59 21.12 -10.84 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 48 SER^? 16.22 C1 EDO A 161 A 48 THR A 43 THR^? 16.73 O2 EDO A 161 A 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 12.68 17.56 -8.98 14.04 19.15 -8.51 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER A 48 SER^? 16.22 C1 EDO A 161 A 48 THR A 43 THR^? 16.73 O2 EDO A 161 A 165 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 12.68 17.56 -8.98 14.04 19.15 -8.51 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 3.53 13.68 -16.08 1.21 12.50 -21.79 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER A 48 SER^? 16.22 C1 EDO A 161 A 48 THR A 47 THR^? 22.44 O1 EDO A 159 A 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 17.01 15.09 -8.48 17.85 13.06 -8.55 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER A 103 SER^? -4.23 C1 EDO A 163s A 48 THR A 104 THR^? 6.75 C1 EDO A 163 A 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 2.38 21.48 -21.38 1.40 20.74 -19.63 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 47 SER A 103 SER^? -4.23 C1 EDO A 163s A 48 THR A 108 THR.? 6.92 C1 EDO A 163 A 165 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 0.06 16.88 -20.13 0.36 17.61 -18.07 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 1.64 29.66 -17.31 7.12 31.17 -15.42 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 47 SER A 105 SER.? 8.19 C1 EDO A 161 A 48 THR A 104 THR^? 6.75 C1 EDO A 163 A 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 6.18 21.11 -21.25 6.99 22.03 -19.15 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 2.38 21.48 -21.38 1.40 20.74 -19.63 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 7.21 11.23 -18.19 10.21 5.87 -19.86 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 48 SER^? 16.22 C1 EDO A 161 B 48 THR A 43 THR^? 16.73 O2 EDO A 161 B 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 15.58 16.01 -11.89 15.60 16.65 -14.21 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 12.68 17.56 -8.98 14.04 19.15 -8.51 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER A 48 SER^? 16.22 C1 EDO A 161 B 48 THR A 43 THR^? 16.73 O2 EDO A 161 B 165 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 15.58 16.01 -11.89 15.60 16.65 -14.21 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 12.68 17.56 -8.98 14.04 19.15 -8.51 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 3.53 13.68 -16.08 1.21 12.50 -21.79 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER A 48 SER^? 16.22 C1 EDO A 161 B 48 THR A 47 THR^? 22.44 O1 EDO A 159 B 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 15.58 16.01 -11.89 15.60 16.65 -14.21 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 17.01 15.09 -8.48 17.85 13.06 -8.55 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 47 SER A 103 SER^? -4.23 C1 EDO A 163s B 48 THR A 104 THR^? 6.75 C1 EDO A 163 B 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 2.38 21.48 -21.38 1.40 20.74 -19.63 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 47 SER A 103 SER^? -4.23 C1 EDO A 163s B 48 THR A 108 THR.? 6.92 C1 EDO A 163 B 165 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 0.06 16.88 -20.13 0.36 17.61 -18.07 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 1.64 29.66 -17.31 7.12 31.17 -15.42 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 47 SER A 105 SER.? 8.19 C1 EDO A 161 B 48 THR A 104 THR^? 6.75 C1 EDO A 163 B 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 6.18 21.11 -21.25 6.99 22.03 -19.15 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 2.38 21.48 -21.38 1.40 20.74 -19.63 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 7.21 11.23 -18.19 10.21 5.87 -19.86 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 48 SER^? 16.22 C1 EDO A 161 C 48 THR A 43 THR^? 16.73 O2 EDO A 161 C 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 12.68 17.56 -8.98 14.04 19.15 -8.51 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER A 48 SER^? 16.22 C1 EDO A 161 C 48 THR A 43 THR^? 16.73 O2 EDO A 161 C 165 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 12.68 17.56 -8.98 14.04 19.15 -8.51 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 3.53 13.68 -16.08 1.21 12.50 -21.79 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER A 48 SER^? 16.22 C1 EDO A 161 C 48 THR A 47 THR^? 22.44 O1 EDO A 159 C 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 17.01 15.09 -8.48 17.85 13.06 -8.55 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER A 103 SER^? -4.23 C1 EDO A 163s C 48 THR A 104 THR^? 6.75 C1 EDO A 163 C 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 2.38 21.48 -21.38 1.40 20.74 -19.63 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 47 SER A 103 SER^? -4.23 C1 EDO A 163s C 48 THR A 108 THR.? 6.92 C1 EDO A 163 C 165 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 0.06 16.88 -20.13 0.36 17.61 -18.07 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 1.64 29.66 -17.31 7.12 31.17 -15.42 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 47 SER A 105 SER.? 8.19 C1 EDO A 161 C 48 THR A 104 THR^? 6.75 C1 EDO A 163 C 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 6.18 21.11 -21.25 6.99 22.03 -19.15 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 2.38 21.48 -21.38 1.40 20.74 -19.63 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 7.21 11.23 -18.19 10.21 5.87 -19.86 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 48 SER^? 16.22 C1 EDO A 161 D 48 THR A 43 THR^? 16.73 O2 EDO A 161 D 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 12.68 17.56 -8.98 14.04 19.15 -8.51 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER A 48 SER^? 16.22 C1 EDO A 161 D 48 THR A 43 THR^? 16.73 O2 EDO A 161 D 165 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 12.68 17.56 -8.98 14.04 19.15 -8.51 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 3.53 13.68 -16.08 1.21 12.50 -21.79 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER A 48 SER^? 16.22 C1 EDO A 161 D 48 THR A 47 THR^? 22.44 O1 EDO A 159 D 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 17.01 15.09 -8.48 17.85 13.06 -8.55 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER A 48 SER^? 16.22 C1 EDO A 161 D 48 THR A 47 THR^? 22.44 O1 EDO A 159 D 165 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 17.01 15.09 -8.48 17.85 13.06 -8.55 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 3.53 13.68 -16.08 1.21 12.50 -21.79 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 47 SER A 103 SER^? -4.23 C1 EDO A 163s D 48 THR A 104 THR^? 6.75 C1 EDO A 163 D 165 LYS A 52 LYS~? 14.37 O1 EDO A 163 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 2.38 21.48 -21.38 1.40 20.74 -19.63 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 7.21 11.23 -18.19 10.21 5.87 -19.86 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 47 SER A 103 SER^? -4.23 C1 EDO A 163s D 48 THR A 108 THR.? 6.92 C1 EDO A 163 D 165 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 0.06 16.88 -20.13 0.36 17.61 -18.07 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 1.64 29.66 -17.31 7.12 31.17 -15.42 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c07 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 55 LYS~? 4.25 C2 EDO A 163 A 331 GLU A 130 GLU~? 11.31 C2 EDO A 163 B 188 HIS A 110 HIS^? 8.51 C1 EDO A 163 coo 130.22 155.23 83.49 125.21 153.71 84.04 3.53 13.68 -16.08 1.21 12.50 -21.79 coo 120.90 152.23 75.28 120.94 153.09 77.19 -7.35 18.96 -14.22 -6.42 19.01 -16.12 coo 122.04 152.80 81.06 120.71 154.37 81.46 -4.32 20.47 -19.07 -2.79 19.74 -17.81 1fuq_c00 source 1fuq FUMARASE C : 1 hits 1fuq_c00 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG A 93 ARG^? 7.83 NA NA A 158 A 201 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 204 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -10.69 28.80 -31.07 -11.04 31.37 -29.39 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -9.50 18.02 -23.12 -8.37 16.46 -23.94 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 1 hits 1g8f_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 130 GLU~? 11.31 C2 EDO A 163 516 HIS A 111 HIS^? 8.62 O2 EDO A 163 559 HIS A 110 HIS^? 8.51 C1 EDO A 163 coo 49.01 14.50 52.53 46.99 14.61 52.78 -7.35 18.96 -14.22 -6.42 19.01 -16.12 coo 41.59 7.83 54.15 41.16 9.87 53.87 -9.50 18.02 -23.12 -8.37 16.46 -23.94 coo 42.22 14.55 52.50 43.91 14.87 53.60 -4.32 20.47 -19.07 -2.79 19.74 -17.81 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 1 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 67 GLU^? 14.56 O1 EDO A 159 A 47 ASP A 35 ASP^? -18.12 O1 EDO A 159s A 161 TYR A 68 TYR^? 16.54 O2 EDO A 161 coo 37.12 18.35 73.76 37.09 16.69 72.44 -0.83 25.67 0.86 -1.19 25.22 2.93 coo 29.81 8.06 73.13 30.21 10.11 72.95 11.16 21.43 -6.03 11.57 21.49 -3.94 coo 37.29 15.56 67.90 37.37 13.79 70.08 0.78 23.48 -5.65 0.20 25.74 -7.17 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 67 GLU^? 14.56 O1 EDO A 159 B 47 ASP A 35 ASP^? -18.12 O1 EDO A 159s B 161 TYR A 68 TYR^? 16.54 O2 EDO A 161 coo 53.87 35.49 53.22 55.44 35.72 54.61 -0.83 25.67 0.86 -1.19 25.22 2.93 coo 63.47 43.65 53.95 61.45 43.07 54.06 11.16 21.43 -6.03 11.57 21.49 -3.94 coo 56.38 35.81 59.19 58.25 35.77 57.10 0.78 23.48 -5.65 0.20 25.74 -7.17 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 1 hits 1geq_c03 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 150 ASN~? 5.62 NA NA A 158 A 108 HIS A 97 HIS.? 9.64 NA NA A 158 A 144 ASP A 153 ASP~? 8.10 NA NA A 158 coo 51.28 61.14 17.85 51.16 61.61 19.96 -12.61 34.90 -31.27 -11.66 33.55 -32.64 coo 52.62 57.63 23.12 50.77 57.51 22.26 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 46.65 56.95 20.09 48.42 58.17 20.01 -12.75 34.73 -26.28 -11.93 33.33 -27.60 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 1 hits 1grc_c02 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 101 ASN^? 9.58 O2 EDO A 163 B 108 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 144 ASP A 114 ASP~? 15.42 NA NA A 158 coo 36.64 101.02 13.15 38.55 101.84 12.78 -7.00 21.19 -26.68 -8.88 20.25 -27.01 coo 41.00 107.18 12.86 42.70 107.82 11.96 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 31.60 110.69 6.14 29.69 109.74 5.94 -12.51 29.33 -20.19 -13.93 30.81 -20.67 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 1 hits 1grc_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 145 PHE~? 8.08 C2 EDO A 162 A 298 ASP A 153 ASP~? 8.10 NA NA A 158 A 329 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -2.74 33.25 -25.54 -4.85 33.57 -23.76 coo 2.59 0.29 25.55 4.65 0.18 25.07 -12.75 34.73 -26.28 -11.93 33.33 -27.60 coo 12.42 6.10 23.27 9.95 1.57 20.16 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 145 PHE~? 8.08 C2 EDO A 162 B 298 ASP A 153 ASP~? 8.10 NA NA A 158 B 329 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -2.74 33.25 -25.54 -4.85 33.57 -23.76 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -12.75 34.73 -26.28 -11.93 33.33 -27.60 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 145 PHE~? 8.08 C2 EDO A 162 C 298 ASP A 153 ASP~? 8.10 NA NA A 158 C 329 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 17.41 60.57 64.39 18.40 58.12 65.34 -2.74 33.25 -25.54 -4.85 33.57 -23.76 coo 24.10 66.43 63.33 24.18 64.30 63.40 -12.75 34.73 -26.28 -11.93 33.33 -27.60 coo 27.64 56.61 58.17 22.18 57.92 60.36 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 145 PHE~? 8.08 C2 EDO A 162 D 298 ASP A 153 ASP~? 8.10 NA NA A 158 D 329 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 35.44 53.35 83.81 35.65 54.53 81.28 -2.74 33.25 -25.54 -4.85 33.57 -23.76 coo 29.72 46.46 83.60 30.79 47.36 81.99 -12.75 34.73 -26.28 -11.93 33.33 -27.60 coo 36.89 44.91 74.55 37.33 48.94 79.01 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 124 SER~? -4.02 O2 EDO A 162s A 164 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 168 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 32.37 52.40 49.35 31.32 53.88 47.74 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 29.69 55.04 42.83 31.98 53.56 43.49 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 26.96 50.99 47.03 31.03 48.83 44.33 1.64 29.66 -17.31 7.12 31.17 -15.42 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 124 SER~? -4.02 O2 EDO A 162s B 164 TYR A 126 TYR^? 6.32 O2 EDO A 162 B 168 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 13.08 50.93 56.67 13.12 48.99 55.27 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 11.52 46.03 51.32 10.06 47.90 52.76 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 15.72 50.86 51.22 10.77 52.35 51.39 1.64 29.66 -17.31 7.12 31.17 -15.42 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 124 SER~? -4.02 O2 EDO A 162s C 164 TYR A 126 TYR^? 6.32 O2 EDO A 162 C 168 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 11.22 34.38 82.32 11.07 36.29 83.78 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 8.83 39.27 87.38 7.60 37.43 85.69 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 12.98 34.46 88.14 8.11 32.96 87.14 1.64 29.66 -17.31 7.12 31.17 -15.42 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 124 SER~? -4.02 O2 EDO A 162s D 164 TYR A 126 TYR^? 6.32 O2 EDO A 162 D 168 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 29.15 32.90 92.57 27.86 31.44 94.02 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 25.49 30.28 98.59 27.88 31.73 98.26 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 23.46 34.31 94.02 27.08 36.46 97.29 1.64 29.66 -17.31 7.12 31.17 -15.42 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_c03 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 79 VAL^? 13.29 O1 EDO A 159 A 200 ASP A 66 ASP.? 19.80 O2 EDO A 162 A 226 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 19.13 38.05 1.41 19.72 38.80 -0.53 4.82 19.96 -3.61 4.36 19.12 -5.60 coo 24.51 43.28 11.18 25.17 44.50 9.58 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo 34.47 51.09 7.19 28.58 51.18 7.53 -5.14 35.78 -15.21 -3.31 32.89 -10.27 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 79 VAL^? 13.29 O1 EDO A 159 A 200 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 226 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 19.13 38.05 1.41 19.72 38.80 -0.53 4.82 19.96 -3.61 4.36 19.12 -5.60 coo 24.51 43.28 11.18 25.17 44.50 9.58 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 34.47 51.09 7.19 28.58 51.18 7.53 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1i29_c03 source 1i29 CSDB : 2 hits 1i29_c03 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 116 LYS~? 17.41 NA NA A 158 B 74 LYS A 119 LYS^? 11.66 O2 EDO A 162 B 165 GLU A 130 GLU~? 11.31 C2 EDO A 163 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -12.02 34.53 -20.62 -15.85 33.24 -18.37 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -5.14 35.78 -15.21 -3.31 32.89 -10.27 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -7.35 18.96 -14.22 -6.42 19.01 -16.12 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 1 hits 1idt_c01 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS A 97 HIS.? 9.64 NA NA A 158 A 167 SER A 98 SER.? 13.43 C2 EDO A 160 A 201 ASN A 155 ASN~? 13.88 NA NA A 158 coo 12.95 4.49 19.05 14.87 4.39 19.77 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 10.44 7.96 22.51 12.16 7.57 20.82 -14.38 26.89 -29.15 -12.90 25.04 -29.74 coo 19.43 6.74 22.83 19.09 5.15 21.60 -19.90 35.20 -25.60 -20.04 36.55 -27.27 ULMN 3 1iph_c00 CATALASE HPII user 2 3 # 2 A 128 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 167 SER A 103 SER^? -4.23 C1 EDO A 163s A 201 ASN A 101 ASN^? 9.58 O2 EDO A 163 coo 12.95 4.49 19.05 14.87 4.39 19.77 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 10.44 7.96 22.51 12.16 7.57 20.82 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo 19.43 6.74 22.83 19.09 5.15 21.60 -7.00 21.19 -26.68 -8.88 20.25 -27.01 1iph_c00 source 1iph CATALASE HPII : 2 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS A 97 HIS.? 9.64 NA NA A 158 B 167 SER A 98 SER.? 13.43 C2 EDO A 160 B 201 ASN A 155 ASN~? 13.88 NA NA A 158 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -14.38 26.89 -29.15 -12.90 25.04 -29.74 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -19.90 35.20 -25.60 -20.04 36.55 -27.27 ULMN 3 1iph_c01 CATALASE HPII user 2 3 # 2 B 128 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 167 SER A 103 SER^? -4.23 C1 EDO A 163s B 201 ASN A 101 ASN^? 9.58 O2 EDO A 163 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -7.00 21.19 -26.68 -8.88 20.25 -27.01 1iph_c01 source 1iph CATALASE HPII : 2 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS A 97 HIS.? 9.64 NA NA A 158 C 167 SER A 98 SER.? 13.43 C2 EDO A 160 C 201 ASN A 155 ASN~? 13.88 NA NA A 158 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -14.38 26.89 -29.15 -12.90 25.04 -29.74 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -19.90 35.20 -25.60 -20.04 36.55 -27.27 ULMN 3 1iph_c02 CATALASE HPII user 2 3 # 2 C 128 HIS A 110 HIS^? 8.51 C1 EDO A 163 C 167 SER A 103 SER^? -4.23 C1 EDO A 163s C 201 ASN A 101 ASN^? 9.58 O2 EDO A 163 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -7.00 21.19 -26.68 -8.88 20.25 -27.01 1iph_c02 source 1iph CATALASE HPII : 2 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS A 97 HIS.? 9.64 NA NA A 158 D 167 SER A 98 SER.? 13.43 C2 EDO A 160 D 201 ASN A 155 ASN~? 13.88 NA NA A 158 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -14.38 26.89 -29.15 -12.90 25.04 -29.74 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -19.90 35.20 -25.60 -20.04 36.55 -27.27 ULMN 3 1iph_c03 CATALASE HPII user 2 3 # 2 D 128 HIS A 110 HIS^? 8.51 C1 EDO A 163 D 167 SER A 103 SER^? -4.23 C1 EDO A 163s D 201 ASN A 101 ASN^? 9.58 O2 EDO A 163 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -7.00 21.19 -26.68 -8.88 20.25 -27.01 1iph_c03 source 1iph CATALASE HPII : 2 hits 1iph_c03 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 41 ASP.? 9.35 C1 EDO A 161 A1134 ALA A 38 ALA.? 6.93 O2 EDO A 161 A1137 ASN A 37 ASN.? 9.37 O2 EDO A 161 coo -27.05 34.58 17.12 -25.81 32.84 17.16 12.12 21.63 -14.87 12.29 22.09 -16.92 coo -20.53 36.39 15.81 -20.80 35.01 16.40 9.44 28.61 -12.65 10.10 29.98 -12.53 coo -23.72 34.69 12.49 -24.32 32.83 13.34 12.10 25.44 -11.22 12.51 24.77 -13.19 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 1 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 204 GLU A 82 GLU.? 10.18 O2 EDO A 161 A 279 TYR A 68 TYR^? 16.54 O2 EDO A 161 coo 5.85 5.60 30.32 5.00 7.49 29.88 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 7.79 1.83 27.81 9.08 3.25 26.92 9.87 29.84 -8.60 11.75 29.89 -9.60 coo 8.22 7.77 18.64 7.58 8.47 21.28 0.78 23.48 -5.65 0.20 25.74 -7.17 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 1 hits 1itx_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 93 ARG^? 7.83 NA NA A 158 A 201 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 204 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -10.69 28.80 -31.07 -11.04 31.37 -29.39 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -9.50 18.02 -23.12 -8.37 16.46 -23.94 1j70_c00 source 1j70 ATP SULPHURYLASE : 1 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 93 ARG^? 7.83 NA NA A 158 B 201 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 204 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -10.69 28.80 -31.07 -11.04 31.37 -29.39 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -9.50 18.02 -23.12 -8.37 16.46 -23.94 1j70_c01 source 1j70 ATP SULPHURYLASE : 1 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 93 ARG^? 7.83 NA NA A 158 C 201 HIS A 110 HIS^? 8.51 C1 EDO A 163 C 204 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo 30.92 14.23 15.70 28.82 13.90 13.48 -10.69 28.80 -31.07 -11.04 31.37 -29.39 coo 20.16 5.55 18.86 20.00 7.59 19.34 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 24.92 3.29 16.90 24.41 4.92 15.69 -9.50 18.02 -23.12 -8.37 16.46 -23.94 1j70_c02 source 1j70 ATP SULPHURYLASE : 1 hits 1j70_c02 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS A 119 LYS^? 11.66 O2 EDO A 162 A 197 HIS A 62 HIS^? 12.35 O2 EDO A 159 A 446 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 3.26 62.02 109.14 4.83 57.73 107.38 -5.14 35.78 -15.21 -3.31 32.89 -10.27 coo 9.48 43.28 113.60 10.05 44.21 111.80 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 12.14 46.28 115.16 13.57 43.60 115.68 -6.19 16.74 -10.46 -4.80 16.75 -13.27 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 2 3 # 2 A 94 LYS A 119 LYS^? 11.66 O2 EDO A 162 A 197 HIS A 97 HIS.? 9.64 NA NA A 158 A 446 ARG A 93 ARG^? 7.83 NA NA A 158 coo 3.26 62.02 109.14 4.83 57.73 107.38 -5.14 35.78 -15.21 -3.31 32.89 -10.27 coo 9.48 43.28 113.60 10.05 44.21 111.80 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 12.14 46.28 115.16 13.57 43.60 115.68 -10.69 28.80 -31.07 -11.04 31.37 -29.39 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 2 hits 1kqf_c03 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 38 ALA.? 6.93 O2 EDO A 161 A 317 GLY A 40 GLY.? 8.20 O2 EDO A 161 A 318 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 9.44 28.61 -12.65 10.10 29.98 -12.53 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 7.90 23.91 -14.98 8.69 23.84 -14.92 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 12.12 21.63 -14.87 12.29 22.09 -16.92 1lij_c01 source 1lij ADENOSINE KINASE : 1 hits 1lij_c01 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 45 HIS A 111 HIS^? 8.62 O2 EDO A 163 A 261 PHE A 91 PHE^? 3.94 C2 EDO A 160 coo 49.89 1.93 30.83 50.54 1.43 32.81 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -9.50 18.02 -23.12 -8.37 16.46 -23.94 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -2.83 27.70 -27.71 -2.24 29.94 -29.22 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS A 111 HIS^? 8.62 O2 EDO A 163 A 45 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 261 PHE A 91 PHE^? 3.94 C2 EDO A 160 coo 49.89 1.93 30.83 50.54 1.43 32.81 -9.50 18.02 -23.12 -8.37 16.46 -23.94 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -2.83 27.70 -27.71 -2.24 29.94 -29.22 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 2 hits 1luc_c00 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 295 GLU A 82 GLU.? 10.18 O2 EDO A 161 A 369 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 11.74 38.14 80.19 10.63 36.40 80.65 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 16.11 33.72 80.99 14.10 33.54 81.63 9.87 29.84 -8.60 11.75 29.89 -9.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 11.16 21.43 -6.03 11.57 21.49 -3.94 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 265 GLU A 130 GLU~? 11.31 C2 EDO A 163 A 369 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 11.74 38.14 80.19 10.63 36.40 80.65 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 17.36 23.57 72.04 18.68 21.92 71.98 -7.35 18.96 -14.22 -6.42 19.01 -16.12 coo 12.19 31.08 87.29 11.13 32.66 86.38 12.12 21.63 -14.87 12.29 22.09 -16.92 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 35 ASP^? -18.12 O1 EDO A 159s A 279 GLU A 75 GLU.? 7.49 O1 EDO A 159s A 369 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 11.74 38.14 80.19 10.63 36.40 80.65 11.16 21.43 -6.03 11.57 21.49 -3.94 coo 16.54 46.37 63.94 14.77 45.79 62.95 1.91 7.28 0.25 3.71 6.79 -0.85 coo 12.19 31.08 87.29 11.13 32.66 86.38 6.13 30.51 -11.36 5.19 32.07 -12.37 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c06 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP A 90 ASP^? -3.94 O2 EDO A 160s A 168 ASN A 101 ASN^? 9.58 O2 EDO A 163 A 241 HIS A 110 HIS^? 8.51 C1 EDO A 163 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 1.27 23.34 -28.00 0.91 23.40 -30.08 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -7.00 21.19 -26.68 -8.88 20.25 -27.01 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -4.32 20.47 -19.07 -2.79 19.74 -17.81 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP A 114 ASP~? 15.42 NA NA A 158 A 168 ASN A 112 ASN^? 14.73 O2 EDO A 163 A 241 HIS A 110 HIS^? 8.51 C1 EDO A 163 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -12.51 29.33 -20.19 -13.93 30.81 -20.67 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -13.14 22.32 -21.21 -14.04 20.67 -22.19 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -4.32 20.47 -19.07 -2.79 19.74 -17.81 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP A 90 ASP^? -3.94 O2 EDO A 160s B 168 ASN A 101 ASN^? 9.58 O2 EDO A 163 B 241 HIS A 110 HIS^? 8.51 C1 EDO A 163 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 1.27 23.34 -28.00 0.91 23.40 -30.08 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -7.00 21.19 -26.68 -8.88 20.25 -27.01 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -4.32 20.47 -19.07 -2.79 19.74 -17.81 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 B 10 ASP A 114 ASP~? 15.42 NA NA A 158 B 168 ASN A 112 ASN^? 14.73 O2 EDO A 163 B 241 HIS A 110 HIS^? 8.51 C1 EDO A 163 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -12.51 29.33 -20.19 -13.93 30.81 -20.67 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -13.14 22.32 -21.21 -14.04 20.67 -22.19 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -4.32 20.47 -19.07 -2.79 19.74 -17.81 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c01 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 78 ARG^? 11.61 O1 EDO A 159 229 SER A 29 SER.? -17.08 O1 EDO A 159s 325 GLU A 30 GLU.? 9.09 O1 EDO A 159 coo 2.54 15.84 18.57 3.24 17.85 16.30 3.40 20.49 2.82 1.01 22.14 3.95 coo 10.17 13.48 15.92 9.61 15.76 15.27 7.43 22.21 8.01 8.60 24.33 7.85 coo 5.42 13.04 19.75 5.74 13.81 17.79 5.78 17.17 4.62 5.27 17.35 2.55 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 1 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 55 LYS~? 4.25 C2 EDO A 163 166 LYS A 52 LYS~? 14.37 O1 EDO A 163 324 SER A 124 SER~? -4.02 O2 EDO A 162s coo 25.93 8.11 25.51 26.40 7.80 19.66 3.53 13.68 -16.08 1.21 12.50 -21.79 coo 27.27 1.43 25.09 29.18 5.25 22.89 7.21 11.23 -18.19 10.21 5.87 -19.86 coo 46.32 14.55 19.93 45.95 12.72 21.27 3.00 36.38 -17.33 4.86 35.21 -16.28 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 1 hits 1mdr_c01 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s 35 SER A 124 SER~? -4.02 O2 EDO A 162s 215 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 20.97 14.47 32.28 19.66 15.96 31.62 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 16.04 14.72 33.82 17.27 13.71 31.95 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 20.65 22.00 33.80 20.06 20.56 32.39 6.13 30.51 -11.36 5.19 32.07 -12.37 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 1 hits 1mpp_c04 naa= 3 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 1 3 # 1 B 237 HIS A 62 HIS^? 12.35 O2 EDO A 159 B 238 GLY A 132 GLY~? 18.03 O2 EDO A 162 B 287 CYH A 63 CYH^? 17.69 O2 EDO A 162 coo 51.19 11.65 88.44 53.07 12.52 88.13 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 45.40 11.66 89.13 45.79 11.98 88.49 -6.96 24.07 -8.94 -6.58 23.67 -9.54 coo 48.33 16.15 90.44 50.61 16.80 91.98 -3.84 23.00 -5.58 -3.19 25.71 -5.69 1nw9_c02 source 1nw9 CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE: 1 hits 1nw9_c02 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 122 ASP~? -11.82 O1 EDO A 162s A 146 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 177 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -3.50 124.89 25.05 -2.25 124.77 23.26 3.64 43.10 -13.91 2.17 44.18 -12.90 coo 1.87 119.38 16.45 1.41 122.11 16.84 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 122 ASP~? -11.82 O1 EDO A 162s B 146 TYR A 126 TYR^? 6.32 O2 EDO A 162 B 177 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -7.43 109.06 51.23 -5.84 110.54 50.86 3.64 43.10 -13.91 2.17 44.18 -12.90 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 122 ASP~? -11.82 O1 EDO A 162s C 146 TYR A 126 TYR^? 6.32 O2 EDO A 162 C 177 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -13.49 79.65 43.90 -12.13 80.29 45.45 3.64 43.10 -13.91 2.17 44.18 -12.90 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 122 ASP~? -11.82 O1 EDO A 162s D 146 TYR A 126 TYR^? 6.32 O2 EDO A 162 D 177 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -13.44 77.36 13.12 -12.53 75.97 14.48 3.64 43.10 -13.91 2.17 44.18 -12.90 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 122 ASP~? -11.82 O1 EDO A 162s E 146 TYR A 126 TYR^? 6.32 O2 EDO A 162 E 177 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -7.12 105.25 1.43 -6.30 103.34 0.77 3.64 43.10 -13.91 2.17 44.18 -12.90 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 122 ASP~? -11.82 O1 EDO A 162s F 146 TYR A 126 TYR^? 6.32 O2 EDO A 162 F 177 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -44.75 128.15 10.28 -45.68 129.67 11.55 3.64 43.10 -13.91 2.17 44.18 -12.90 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 122 ASP~? -11.82 O1 EDO A 162s G 146 TYR A 126 TYR^? 6.32 O2 EDO A 162 G 177 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -44.97 128.78 41.20 -46.32 128.26 42.83 3.64 43.10 -13.91 2.17 44.18 -12.90 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 122 ASP~? -11.82 O1 EDO A 162s H 146 TYR A 126 TYR^? 6.32 O2 EDO A 162 H 177 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -51.11 100.30 51.41 -52.67 98.82 51.12 3.64 43.10 -13.91 2.17 44.18 -12.90 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 122 ASP~? -11.82 O1 EDO A 162s I 146 TYR A 126 TYR^? 6.32 O2 EDO A 162 I 177 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -54.65 81.97 26.87 -55.88 81.89 25.07 3.64 43.10 -13.91 2.17 44.18 -12.90 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 122 ASP~? -11.82 O1 EDO A 162s J 146 TYR A 126 TYR^? 6.32 O2 EDO A 162 J 177 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo -50.64 99.08 1.52 -51.52 100.83 0.67 3.64 43.10 -13.91 2.17 44.18 -12.90 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c09 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 78 ARG^? 11.61 O1 EDO A 159 A 479 PHE A 69 PHE^? 9.97 O1 EDO A 159 A 483 GLU A 67 GLU^? 14.56 O1 EDO A 159 coo 17.33 52.29 2.24 18.71 54.03 0.18 3.40 20.49 2.82 1.01 22.14 3.95 coo 20.06 57.44 1.28 18.39 56.19 3.12 -1.45 18.98 -0.92 -1.58 20.89 1.07 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -0.83 25.67 0.86 -1.19 25.22 2.93 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 1 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 78 ARG^? 11.61 O1 EDO A 159 B 479 PHE A 69 PHE^? 9.97 O1 EDO A 159 B 483 GLU A 67 GLU^? 14.56 O1 EDO A 159 coo -26.72 93.28 20.13 -28.02 93.55 17.39 3.40 20.49 2.82 1.01 22.14 3.95 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -1.45 18.98 -0.92 -1.58 20.89 1.07 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -0.83 25.67 0.86 -1.19 25.22 2.93 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 1 hits 1pow_c03 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 68 ALA A 38 ALA.? 6.93 O2 EDO A 161 A 72 LEU A 39 LEU.? 6.20 O2 EDO A 161 coo 46.76 7.59 18.65 45.27 6.01 18.52 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 48.88 4.35 16.59 48.73 5.09 15.20 9.44 28.61 -12.65 10.10 29.98 -12.53 coo 53.89 6.25 15.09 52.88 7.92 14.14 11.39 26.79 -16.68 12.43 25.10 -17.45 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 68 ALA A 84 ALA.? 8.97 O2 EDO A 162 A 72 LEU A 86 LEU^? 10.77 C1 EDO A 163 coo 46.76 7.59 18.65 45.27 6.01 18.52 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 48.88 4.35 16.59 48.73 5.09 15.20 2.76 27.88 -11.85 2.16 28.28 -13.17 coo 53.89 6.25 15.09 52.88 7.92 14.14 1.18 23.08 -15.82 0.57 21.02 -15.41 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 2 hits 1q6l_c05 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 C 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 C 236 ASP A 65 ASP.? 16.31 O2 EDO A 159 coo 39.01 29.77 22.02 37.48 31.30 19.84 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo 39.51 34.34 13.63 37.63 32.61 14.79 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 45.78 31.11 9.51 44.25 30.06 10.53 -6.39 26.44 0.83 -8.34 25.81 1.27 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 C 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 C 236 ASP A 66 ASP.? 19.80 O2 EDO A 162 coo 39.01 29.77 22.02 37.48 31.30 19.84 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo 39.51 34.34 13.63 37.63 32.61 14.79 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 45.78 31.11 9.51 44.25 30.06 10.53 -2.90 29.23 -2.02 -4.63 30.38 -2.07 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 D 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 D 236 ASP A 65 ASP.? 16.31 O2 EDO A 159 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -6.39 26.44 0.83 -8.34 25.81 1.27 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 D 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 D 236 ASP A 66 ASP.? 19.80 O2 EDO A 162 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -2.90 29.23 -2.02 -4.63 30.38 -2.07 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 A 236 ASP A 65 ASP.? 16.31 O2 EDO A 159 C 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 55.48 26.51 40.65 55.39 23.99 39.43 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 48.87 29.19 44.63 49.10 27.34 43.63 -6.39 26.44 0.83 -8.34 25.81 1.27 coo 52.39 23.42 32.10 54.51 23.27 34.29 -6.19 16.74 -10.46 -4.80 16.75 -13.27 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 A 236 ASP A 66 ASP.? 19.80 O2 EDO A 162 C 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 55.48 26.51 40.65 55.39 23.99 39.43 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 48.87 29.19 44.63 49.10 27.34 43.63 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo 52.39 23.42 32.10 54.51 23.27 34.29 -6.19 16.74 -10.46 -4.80 16.75 -13.27 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 B 236 ASP A 66 ASP.? 19.80 O2 EDO A 162 D 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -6.19 16.74 -10.46 -4.80 16.75 -13.27 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 G 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 G 236 ASP A 65 ASP.? 16.31 O2 EDO A 159 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -6.39 26.44 0.83 -8.34 25.81 1.27 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 G 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 G 236 ASP A 66 ASP.? 19.80 O2 EDO A 162 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -2.90 29.23 -2.02 -4.63 30.38 -2.07 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 H 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 H 236 ASP A 66 ASP.? 19.80 O2 EDO A 162 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -6.19 16.74 -10.46 -4.80 16.75 -13.27 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -2.90 29.23 -2.02 -4.63 30.38 -2.07 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 E 236 ASP A 66 ASP.? 19.80 O2 EDO A 162 G 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -6.19 16.74 -10.46 -4.80 16.75 -13.27 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 F 236 ASP A 65 ASP.? 16.31 O2 EDO A 159 H 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -6.39 26.44 0.83 -8.34 25.81 1.27 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -6.19 16.74 -10.46 -4.80 16.75 -13.27 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 68 TYR^? 16.54 O2 EDO A 161 F 236 ASP A 66 ASP.? 19.80 O2 EDO A 162 H 110 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -6.19 16.74 -10.46 -4.80 16.75 -13.27 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 83 ASP.? 7.90 O2 EDO A 161 A 256 GLU A 82 GLU.? 10.18 O2 EDO A 161 A 329 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 28.46 69.88 26.74 30.40 70.70 26.53 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 30.54 71.65 32.58 31.73 72.26 30.92 9.87 29.84 -8.60 11.75 29.89 -9.60 coo 37.87 70.12 31.80 36.61 69.74 30.15 11.16 21.43 -6.03 11.57 21.49 -3.94 1qho_c04 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 41 ASP.? 9.35 C1 EDO A 161 A 261 ASP A 66 ASP.? 19.80 O2 EDO A 162 A 329 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 28.46 69.88 26.74 30.40 70.70 26.53 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 34.02 79.89 42.60 34.73 78.01 41.86 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 11.16 21.43 -6.03 11.57 21.49 -3.94 1qho_c05 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 35 ASP^? -18.12 O1 EDO A 159s A 260 ASP A 66 ASP.? 19.80 O2 EDO A 162 A 329 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 28.46 69.88 26.74 30.40 70.70 26.53 11.16 21.43 -6.03 11.57 21.49 -3.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 6.13 30.51 -11.36 5.19 32.07 -12.37 1qho_c07 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 121 THR~? 7.82 O2 EDO A 162 A 182 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 186 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 69.38 87.38 24.64 71.11 88.47 25.40 0.49 39.42 -13.60 1.55 37.66 -13.04 coo 73.61 90.42 31.12 71.36 89.66 29.64 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 73.54 84.00 28.64 69.01 86.68 29.71 -5.14 35.78 -15.21 -3.31 32.89 -10.27 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 1 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 646 ASP A 90 ASP^? -3.94 O2 EDO A 160s A 739 GLY A 40 GLY.? 8.20 O2 EDO A 161 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo -18.83 7.68 26.86 -20.89 7.78 26.56 1.27 23.34 -28.00 0.91 23.40 -30.08 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 7.90 23.91 -14.98 8.69 23.84 -14.92 1qrz_c20 source 1qrz PLASMINOGEN : 1 hits 1qrz_c20 naa= 3 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 1 3 # 1 A 317 HIS A 62 HIS^? 12.35 O2 EDO A 159 A 318 GLY A 132 GLY~? 18.03 O2 EDO A 162 A 360 CYH A 63 CYH^? 17.69 O2 EDO A 162 coo -8.43 39.80 36.26 -8.18 39.59 38.31 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo -11.14 38.10 31.61 -11.46 38.10 32.37 -6.96 24.07 -8.94 -6.58 23.67 -9.54 coo -11.95 34.09 34.07 -11.89 34.73 36.80 -3.84 23.00 -5.58 -3.19 25.71 -5.69 1qtn_c02 source 1qtn ACETYL-ILE-GLU-THR-ASP-ALDEHYDE : 1 hits 1qtn_c02 naa= 3 ULMN 3 1qx3_c00 APOPAIN user 1 3 # 1 A 121 HIS A 62 HIS^? 12.35 O2 EDO A 159 A 122 GLY A 132 GLY~? 18.03 O2 EDO A 162 A 163 CYH A 63 CYH^? 17.69 O2 EDO A 162 coo 2.23 29.11 15.20 1.24 27.27 15.13 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 2.54 34.86 14.60 1.83 34.53 14.82 -6.96 24.07 -8.94 -6.58 23.67 -9.54 coo -1.20 35.13 11.95 -2.11 32.67 12.98 -3.84 23.00 -5.58 -3.19 25.71 -5.69 1qx3_c00 source 1qx3 APOPAIN : 1 hits 1qx3_c00 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 34 PHE^? 12.69 O1 EDO A 159 A 201 ASP A 35 ASP^? -18.12 O1 EDO A 159s A 227 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo 23.39 49.81 32.16 21.33 51.68 32.26 7.43 15.53 -5.36 7.24 12.73 -5.43 coo 25.52 45.12 37.98 23.98 46.65 37.85 11.16 21.43 -6.03 11.57 21.49 -3.94 coo 12.68 46.83 36.69 18.26 48.67 34.51 3.53 13.68 -16.08 1.21 12.50 -21.79 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 91 PHE^? 3.94 C2 EDO A 160 A 201 ASP A 90 ASP^? -3.94 O2 EDO A 160s A 227 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 23.39 49.81 32.16 21.33 51.68 32.26 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo 25.52 45.12 37.98 23.98 46.65 37.85 1.27 23.34 -28.00 0.91 23.40 -30.08 coo 12.68 46.83 36.69 18.26 48.67 34.51 1.64 29.66 -17.31 7.12 31.17 -15.42 1qz9_c02 source 1qz9 KYNURENINASE : 2 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 35 ASP^? -18.12 O1 EDO A 159s A 186 ASN A 37 ASN.? 9.37 O2 EDO A 161 A 260 ALA A 84 ALA.? 8.97 O2 EDO A 162 coo 11.81 33.10 11.71 13.07 31.45 11.40 11.16 21.43 -6.03 11.57 21.49 -3.94 coo 11.43 26.53 7.41 13.01 27.56 8.43 12.10 25.44 -11.22 12.51 24.77 -13.19 coo 21.53 26.33 6.96 20.26 25.69 7.52 2.76 27.88 -11.85 2.16 28.28 -13.17 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 114 ASP~? 15.42 NA NA A 158 A 186 ASN A 112 ASN^? 14.73 O2 EDO A 163 A 260 ALA A 94 ALA.? 13.55 O2 EDO A 163 coo 11.81 33.10 11.71 13.07 31.45 11.40 -12.51 29.33 -20.19 -13.93 30.81 -20.67 coo 11.43 26.53 7.41 13.01 27.56 8.43 -13.14 22.32 -21.21 -14.04 20.67 -22.19 coo 21.53 26.33 6.96 20.26 25.69 7.52 -11.22 22.00 -31.24 -12.14 21.25 -30.23 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 2 hits 1r4f_c00 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 41 LYS A 55 LYS~? 4.25 C2 EDO A 163 A 119 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 3.53 13.68 -16.08 1.21 12.50 -21.79 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -9.50 18.02 -23.12 -8.37 16.46 -23.94 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 41 LYS A 136 LYS^? 4.23 O2 EDO A 161 A 119 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 1.64 29.66 -17.31 7.12 31.17 -15.42 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -9.50 18.02 -23.12 -8.37 16.46 -23.94 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 2 hits 1rbn_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 41 ASP.? 9.35 C1 EDO A 161 35 SER A 48 SER^? 16.22 C1 EDO A 161 215 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 11.85 17.24 72.81 11.09 15.37 72.36 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 12.20 12.71 75.45 13.69 13.84 74.03 15.58 16.01 -11.89 15.60 16.65 -14.21 coo 5.22 15.03 71.43 7.19 14.88 70.83 11.16 21.43 -6.03 11.57 21.49 -3.94 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s 35 SER A 124 SER~? -4.02 O2 EDO A 162s 215 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 11.85 17.24 72.81 11.09 15.37 72.36 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 12.20 12.71 75.45 13.69 13.84 74.03 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 5.22 15.03 71.43 7.19 14.88 70.83 6.13 30.51 -11.36 5.19 32.07 -12.37 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s 35 SER A 124 SER~? -4.02 O2 EDO A 162s 215 ASP A 122 ASP~? -11.82 O1 EDO A 162s coo 11.85 17.24 72.81 11.09 15.37 72.36 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 12.20 12.71 75.45 13.69 13.84 74.03 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 5.22 15.03 71.43 7.19 14.88 70.83 3.64 43.10 -13.91 2.17 44.18 -12.90 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 3 hits 1rne_c04 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 75 GLU.? 7.49 O1 EDO A 159s A 288 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 329 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 29.27 18.78 14.99 27.16 18.62 14.76 1.91 7.28 0.25 3.71 6.79 -0.85 coo 49.52 10.06 10.36 50.99 9.65 8.92 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 57.80 12.92 13.83 53.77 8.42 12.15 1.64 29.66 -17.31 7.12 31.17 -15.42 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 75 GLU.? 7.49 O1 EDO A 159s B 288 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 329 LYS A 136 LYS^? 4.23 O2 EDO A 161 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 1.91 7.28 0.25 3.71 6.79 -0.85 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 1.64 29.66 -17.31 7.12 31.17 -15.42 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c01 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS A 110 HIS^? 8.51 C1 EDO A 163 62 GLU A 130 GLU~? 11.31 C2 EDO A 163 101 HIS A 62 HIS^? 12.35 O2 EDO A 159 coo 13.91 26.31 13.70 14.98 27.08 12.06 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 9.15 26.32 13.85 8.75 28.20 13.02 -7.35 18.96 -14.22 -6.42 19.01 -16.12 coo 7.90 34.31 7.89 9.24 33.73 9.42 -5.47 17.51 -6.29 -6.49 15.78 -6.92 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 1 hits 1rtu_c00 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 123 ASP~? -8.02 O1 EDO A 162s A 37 SER A 124 SER~? -4.02 O2 EDO A 162s A 214 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 51.75 60.57 19.10 52.05 60.90 21.19 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 51.10 65.11 20.73 52.62 63.74 19.42 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 48.59 58.89 25.78 50.13 59.74 24.61 6.13 30.51 -11.36 5.19 32.07 -12.37 1sme_c04 source 1sme PLASMEPSIN II : 1 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 123 ASP~? -8.02 O1 EDO A 162s B 37 SER A 124 SER~? -4.02 O2 EDO A 162s B 214 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 17.69 97.58 52.73 17.33 97.19 54.77 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 20.67 100.44 55.84 20.21 98.51 54.45 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 12.41 98.71 58.47 14.37 98.17 58.05 6.13 30.51 -11.36 5.19 32.07 -12.37 1sme_c05 source 1sme PLASMEPSIN II : 1 hits 1sme_c05 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 103 SER^? -4.23 C1 EDO A 163s A 90 SER A 105 SER.? 8.19 C1 EDO A 161 A 145 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo 1.47 40.03 18.48 2.45 41.37 16.68 6.18 21.11 -21.25 6.99 22.03 -19.15 coo 7.35 44.71 16.29 4.71 40.98 14.52 3.53 13.68 -16.08 1.21 12.50 -21.79 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 1 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 103 SER^? -4.23 C1 EDO A 163s B 90 SER A 105 SER.? 8.19 C1 EDO A 161 B 145 LYS A 55 LYS~? 4.25 C2 EDO A 163 coo 61.01 10.03 12.97 58.78 10.97 12.69 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo 56.85 12.22 16.37 55.62 11.34 14.45 6.18 21.11 -21.25 6.99 22.03 -19.15 coo 49.80 9.51 14.88 53.14 11.99 12.77 3.53 13.68 -16.08 1.21 12.50 -21.79 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 1 hits 1t7d_c01 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 38 ALA.? 6.93 O2 EDO A 161 A 251 GLY A 40 GLY.? 8.20 O2 EDO A 161 A 252 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 9.44 28.61 -12.65 10.10 29.98 -12.53 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 7.90 23.91 -14.98 8.69 23.84 -14.92 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 12.12 21.63 -14.87 12.29 22.09 -16.92 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 1 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 38 ALA.? 6.93 O2 EDO A 161 B 251 GLY A 40 GLY.? 8.20 O2 EDO A 161 B 252 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 9.44 28.61 -12.65 10.10 29.98 -12.53 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 7.90 23.91 -14.98 8.69 23.84 -14.92 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 12.12 21.63 -14.87 12.29 22.09 -16.92 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 1 hits 1tz3_c03 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 116 LYS~? 17.41 NA NA A 158 138 ASN A 155 ASN~? 13.88 NA NA A 158 183 HIS A 97 HIS.? 9.64 NA NA A 158 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -12.02 34.53 -20.62 -15.85 33.24 -18.37 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -19.90 35.20 -25.60 -20.04 36.55 -27.27 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -15.78 31.45 -33.05 -15.49 32.94 -34.49 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 1 hits 1uag_c01 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 83 ASP.? 7.90 O2 EDO A 161 255 GLU A 82 GLU.? 10.18 O2 EDO A 161 329 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 49.16 35.16 15.19 51.08 34.43 15.65 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 52.57 37.12 10.17 53.37 35.95 11.75 9.87 29.84 -8.60 11.75 29.89 -9.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 11.16 21.43 -6.03 11.57 21.49 -3.94 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 1 hits 1uok_c03 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 83 ASP.? 7.90 O2 EDO A 161 242 GLU A 30 GLU.? 9.09 O1 EDO A 159 329 ASP A 123 ASP~? -8.02 O1 EDO A 162s coo 49.16 35.16 15.19 51.08 34.43 15.65 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 30.42 34.74 5.00 29.09 35.09 3.38 5.78 17.17 4.62 5.27 17.35 2.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 6.11 38.48 -15.06 7.29 39.80 -13.91 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 83 ASP.? 7.90 O2 EDO A 161 242 GLU A 148 GLU~? 6.95 NA NA A 158 329 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 49.16 35.16 15.19 51.08 34.43 15.65 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 30.42 34.74 5.00 29.09 35.09 3.38 -6.53 31.30 -30.27 -6.73 30.41 -32.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 11.16 21.43 -6.03 11.57 21.49 -3.94 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c05 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 44 TYR^? 14.32 O1 EDO A 159 A 40 ASP A 41 ASP.? 9.35 C1 EDO A 161 A 103 LEU A 49 LEU.? 16.75 O1 EDO A 163 coo 12.09 16.13 10.57 11.28 18.80 10.73 11.26 12.68 -5.54 10.51 10.98 -3.44 coo 7.55 25.51 14.34 9.65 25.73 14.24 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 11.83 18.73 16.99 10.99 19.71 15.26 11.12 14.13 -12.33 10.52 13.20 -10.46 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 40 ASP A 122 ASP~? -11.82 O1 EDO A 162s A 103 LEU A 120 LEU^? 8.44 O2 EDO A 162 coo 12.09 16.13 10.57 11.28 18.80 10.73 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 7.55 25.51 14.34 9.65 25.73 14.24 3.64 43.10 -13.91 2.17 44.18 -12.90 coo 11.83 18.73 16.99 10.99 19.71 15.26 -2.55 39.45 -16.73 -3.58 39.30 -18.69 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 126 TYR^? 6.32 O2 EDO A 162 B 40 ASP A 122 ASP~? -11.82 O1 EDO A 162s B 103 LEU A 120 LEU^? 8.44 O2 EDO A 162 coo 14.25 20.09 37.35 13.48 17.40 37.38 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 9.39 10.77 34.53 11.50 10.63 34.41 3.64 43.10 -13.91 2.17 44.18 -12.90 coo 12.89 17.60 31.13 12.34 16.51 32.90 -2.55 39.45 -16.73 -3.58 39.30 -18.69 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 126 TYR^? 6.32 O2 EDO A 162 B 40 ASP A 123 ASP~? -8.02 O1 EDO A 162s B 103 LEU A 120 LEU^? 8.44 O2 EDO A 162 coo 14.25 20.09 37.35 13.48 17.40 37.38 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 9.39 10.77 34.53 11.50 10.63 34.41 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 12.89 17.60 31.13 12.34 16.51 32.90 -2.55 39.45 -16.73 -3.58 39.30 -18.69 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c01 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR A 72 THR.? 7.55 C2 EDO A 159 A 345 PHE A 69 PHE^? 9.97 O1 EDO A 159 A 352 CYH A 63 CYH^? 17.69 O2 EDO A 162 coo 9.58 21.79 21.50 11.25 23.03 20.90 -3.45 9.25 -3.33 -1.45 8.50 -3.70 coo 19.40 19.75 18.58 17.39 17.81 18.80 -1.45 18.98 -0.92 -1.58 20.89 1.07 coo 21.57 22.52 22.79 19.20 21.13 23.26 -3.84 23.00 -5.58 -3.19 25.71 -5.69 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 2 3 # 2 A 243 THR A 104 THR^? 6.75 C1 EDO A 163 A 345 PHE A 91 PHE^? 3.94 C2 EDO A 160 A 352 CYH A 141 CYH~? -4.10 O1 EDO A 160s coo 9.58 21.79 21.50 11.25 23.03 20.90 2.38 21.48 -21.38 1.40 20.74 -19.63 coo 19.40 19.75 18.58 17.39 17.81 18.80 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo 21.57 22.52 22.79 19.20 21.13 23.26 3.42 30.61 -27.67 3.13 28.26 -26.13 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 2 hits 1xqd_c02 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 134 TRP^? 12.55 O2 EDO A 162 223 ASP A 83 ASP.? 7.90 O2 EDO A 161 258 ALA A 58 ALA~? 11.18 C2 EDO A 163 coo 128.40 33.01 26.67 128.12 36.28 28.81 -4.49 28.61 -10.89 -6.53 31.22 -12.96 coo 127.91 41.73 23.55 129.18 40.35 24.44 6.13 30.51 -11.36 5.19 32.07 -12.37 coo 141.00 37.49 25.74 139.80 37.53 24.78 1.01 15.62 -12.35 1.30 16.32 -13.67 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 1 hits 2aat_c01 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 97 HIS.? 9.64 NA NA A 158 B 50 GLU A 92 GLU^? 8.42 O2 EDO A 160 B 113 GLN A 95 GLN.? 16.27 NA NA A 158 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -15.82 23.39 -34.54 -17.53 24.64 -34.99 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 97 HIS.? 9.64 NA NA A 158 B 50 GLU A 92 GLU^? 8.42 O2 EDO A 160 B 113 GLN A 95 GLN.? 16.27 NA NA A 158 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -15.82 23.39 -34.54 -17.53 24.64 -34.99 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 97 HIS.? 9.64 NA NA A 158 A 50 GLU A 92 GLU^? 8.42 O2 EDO A 160 A 113 GLN A 95 GLN.? 16.27 NA NA A 158 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -15.82 23.39 -34.54 -17.53 24.64 -34.99 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 97 HIS.? 9.64 NA NA A 158 C 50 GLU A 92 GLU^? 8.42 O2 EDO A 160 C 113 GLN A 95 GLN.? 16.27 NA NA A 158 coo 74.92 8.52 28.42 74.88 6.86 29.70 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 65.25 15.95 28.73 65.73 15.63 30.78 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo 70.80 6.73 32.72 71.88 8.55 32.53 -15.82 23.39 -34.54 -17.53 24.64 -34.99 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 97 HIS.? 9.64 NA NA A 158 D 50 GLU A 92 GLU^? 8.42 O2 EDO A 160 D 113 GLN A 95 GLN.? 16.27 NA NA A 158 coo 38.66 11.31 27.15 38.67 12.13 25.22 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 48.72 12.85 33.83 48.36 14.77 32.95 -6.10 23.33 -32.41 -5.72 21.53 -33.42 coo 42.85 14.77 24.15 41.85 15.11 26.02 -15.82 23.39 -34.54 -17.53 24.64 -34.99 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 35 ASP^? -18.12 O1 EDO A 159s 231 ASP A 122 ASP~? -11.82 O1 EDO A 162s 294 ASP A 41 ASP.? 9.35 C1 EDO A 161 coo 27.89 102.52 14.98 29.35 101.92 13.57 11.16 21.43 -6.03 11.57 21.49 -3.94 coo 14.74 93.05 -1.00 14.30 94.22 0.73 3.64 43.10 -13.91 2.17 44.18 -12.90 coo 33.16 106.80 7.72 33.34 104.87 6.92 12.12 21.63 -14.87 12.29 22.09 -16.92 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 41 ASP.? 9.35 C1 EDO A 161 231 ASP A 122 ASP~? -11.82 O1 EDO A 162s 294 ASP A 35 ASP^? -18.12 O1 EDO A 159s coo 27.89 102.52 14.98 29.35 101.92 13.57 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 14.74 93.05 -1.00 14.30 94.22 0.73 3.64 43.10 -13.91 2.17 44.18 -12.90 coo 33.16 106.80 7.72 33.34 104.87 6.92 11.16 21.43 -6.03 11.57 21.49 -3.94 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 123 ASP~? -8.02 O1 EDO A 162s 231 ASP A 153 ASP~? 8.10 NA NA A 158 294 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 27.89 102.52 14.98 29.35 101.92 13.57 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -12.75 34.73 -26.28 -11.93 33.33 -27.60 coo 33.16 106.80 7.72 33.34 104.87 6.92 6.13 30.51 -11.36 5.19 32.07 -12.37 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 3 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 123 ASP~? -8.02 O1 EDO A 162s 38 SER A 124 SER~? -4.02 O2 EDO A 162s 218 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo 41.14 58.72 105.19 42.39 59.85 103.92 6.11 38.48 -15.06 7.29 39.80 -13.91 coo 46.04 57.35 103.96 44.97 58.52 105.78 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 41.33 60.20 97.63 42.00 60.96 99.49 6.13 30.51 -11.36 5.19 32.07 -12.37 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 1 hits 2apr_c04 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 62 HIS^? 12.35 O2 EDO A 159 B 163 ALA A 58 ALA~? 11.18 C2 EDO A 163 B 182 SER A 59 SER~? 13.17 C2 EDO A 163 coo 30.42 1.98 4.36 29.07 0.41 4.68 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 1.01 15.62 -12.35 1.30 16.32 -13.67 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -1.97 13.24 -12.75 -1.33 10.88 -12.38 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 1 hits 2bhg_c02 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR A 104 THR^? 6.75 C1 EDO A 163 242 CYH A 141 CYH~? -4.10 O1 EDO A 160s 270 PHE A 91 PHE^? 3.94 C2 EDO A 160 coo 12.97 28.35 3.84 11.81 28.07 2.09 2.38 21.48 -21.38 1.40 20.74 -19.63 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 3.42 30.61 -27.67 3.13 28.26 -26.13 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -2.83 27.70 -27.71 -2.24 29.94 -29.22 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 1 hits 2cnd_c01 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 142 TYR~? 4.26 C2 EDO A 162s A 245 ASP A 123 ASP~? -8.02 O1 EDO A 162s A 273 LYS A 119 LYS^? 11.66 O2 EDO A 162 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 2.93 36.19 -24.94 1.69 38.47 -23.92 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 6.11 38.48 -15.06 7.29 39.80 -13.91 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -5.14 35.78 -15.21 -3.31 32.89 -10.27 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 1 hits 2gsa_c02 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER A 103 SER^? -4.23 C1 EDO A 163s B 158 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 208 ASN A 101 ASN^? 9.58 O2 EDO A 163 coo 50.29 50.10 71.46 47.85 50.06 71.46 -0.52 20.98 -23.72 0.63 20.73 -25.82 coo 48.67 45.40 71.68 47.67 46.90 70.60 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 48.91 49.12 65.17 47.29 49.14 66.54 -7.00 21.19 -26.68 -8.88 20.25 -27.01 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 2 3 # 2 B 137 SER A 152 SER~? 9.44 NA NA A 158 B 158 HIS A 97 HIS.? 9.64 NA NA A 158 B 208 ASN A 155 ASN~? 13.88 NA NA A 158 coo 50.29 50.10 71.46 47.85 50.06 71.46 -16.65 35.73 -29.03 -15.84 33.90 -30.36 coo 48.67 45.40 71.68 47.67 46.90 70.60 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 48.91 49.12 65.17 47.29 49.14 66.54 -19.90 35.20 -25.60 -20.04 36.55 -27.27 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 2 hits 2hdh_c02 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 341 GLU A 130 GLU~? 11.31 C2 EDO A 163 A 356 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo 121.00 36.37 19.26 121.57 38.37 19.56 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 125.72 32.70 19.75 124.44 34.16 18.84 -7.35 18.96 -14.22 -6.42 19.01 -16.12 coo 124.34 41.73 25.55 123.79 42.60 23.72 -9.50 18.02 -23.12 -8.37 16.46 -23.94 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 1 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 341 GLU A 130 GLU~? 11.31 C2 EDO A 163 B 356 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -7.35 18.96 -14.22 -6.42 19.01 -16.12 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -9.50 18.02 -23.12 -8.37 16.46 -23.94 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 1 hits 2isd_c01 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 123 ASP~? -8.02 O1 EDO A 162s A 35 SER A 124 SER~? -4.02 O2 EDO A 162s A 215 ASP A 83 ASP.? 7.90 O2 EDO A 161 coo -14.00 61.45 43.99 -14.19 63.14 42.84 6.11 38.48 -15.06 7.29 39.80 -13.91 coo -13.21 66.21 45.84 -15.49 65.90 45.84 3.00 36.38 -17.33 4.86 35.21 -16.28 coo -10.72 64.19 37.77 -12.20 64.43 39.15 6.13 30.51 -11.36 5.19 32.07 -12.37 2jxr_c04 source 2jxr LIGAND CP-081282 : 1 hits 2jxr_c04 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 40 LYS A 55 LYS~? 4.25 C2 EDO A 163 A 116 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 18.50 3.53 20.10 16.17 2.61 14.41 3.53 13.68 -16.08 1.21 12.50 -21.79 coo 14.70 6.01 5.61 14.27 7.69 6.78 -9.50 18.02 -23.12 -8.37 16.46 -23.94 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS A 110 HIS^? 8.51 C1 EDO A 163 A 40 LYS A 136 LYS^? 4.23 O2 EDO A 161 A 116 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 18.50 3.53 20.10 16.17 2.61 14.41 1.64 29.66 -17.31 7.12 31.17 -15.42 coo 14.70 6.01 5.61 14.27 7.69 6.78 -9.50 18.02 -23.12 -8.37 16.46 -23.94 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 2 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 40 LYS A 55 LYS~? 4.25 C2 EDO A 163 B 116 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo -10.61 31.45 9.72 -8.75 26.69 13.45 3.53 13.68 -16.08 1.21 12.50 -21.79 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -9.50 18.02 -23.12 -8.37 16.46 -23.94 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS A 110 HIS^? 8.51 C1 EDO A 163 B 40 LYS A 136 LYS^? 4.23 O2 EDO A 161 B 116 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo -10.61 31.45 9.72 -8.75 26.69 13.45 1.64 29.66 -17.31 7.12 31.17 -15.42 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -9.50 18.02 -23.12 -8.37 16.46 -23.94 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 2 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 122 ASP~? -11.82 O1 EDO A 162s 166 GLY A 135 GLY^? 9.03 O2 EDO A 162 169 GLU A 130 GLU~? 11.31 C2 EDO A 163 coo 8.28 6.87 1.62 10.08 5.77 1.34 3.64 43.10 -13.91 2.17 44.18 -12.90 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -0.79 26.83 -16.51 -1.09 27.58 -16.27 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.35 18.96 -14.22 -6.42 19.01 -16.12 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 1 hits 2tdt_c00 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 110 HIS^? 8.51 C1 EDO A 163 41 LYS A 55 LYS~? 4.25 C2 EDO A 163 119 HIS A 111 HIS^? 8.62 O2 EDO A 163 coo 28.18 18.67 11.43 28.83 17.39 9.89 -4.32 20.47 -19.07 -2.79 19.74 -17.81 coo 25.33 8.32 6.30 27.86 13.90 7.82 3.53 13.68 -16.08 1.21 12.50 -21.79 coo 33.68 19.99 5.35 34.98 18.36 5.19 -9.50 18.02 -23.12 -8.37 16.46 -23.94 5rsa_c01 source 5rsa RIBONUCLEASE A : 1 hits 5rsa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 37 ASN.? 9.37 O2 EDO A 161 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.10 25.44 -11.22 12.51 24.77 -13.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 101 ASN^? 9.58 O2 EDO A 163 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.00 21.19 -26.68 -8.88 20.25 -27.01 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 112 ASN^? 14.73 O2 EDO A 163 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.14 22.32 -21.21 -14.04 20.67 -22.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 144 ASN~? -3.85 O1 EDO A 160s coo 5.80 63.03 55.85 5.52 65.03 56.45 0.74 31.64 -31.25 2.27 31.36 -32.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 147 ASN~? 3.98 O1 EDO A 164s coo 5.80 63.03 55.85 5.52 65.03 56.45 -2.38 35.71 -33.15 -0.60 36.82 -33.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 150 ASN~? 5.62 NA NA A 158 coo 5.80 63.03 55.85 5.52 65.03 56.45 -12.61 34.90 -31.27 -11.66 33.55 -32.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 155 ASN~? 13.88 NA NA A 158 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.90 35.20 -25.60 -20.04 36.55 -27.27 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 7 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 142 TYR~? 4.26 C2 EDO A 162s A 112 PHE A 91 PHE^? 3.94 C2 EDO A 160 A 140 ASN A 144 ASN~? -3.85 O1 EDO A 160s coo -6.29 44.15 17.65 -9.00 44.92 17.68 2.93 36.19 -24.94 1.69 38.47 -23.92 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo -4.46 50.64 12.29 -5.69 49.89 13.85 0.74 31.64 -31.25 2.27 31.36 -32.72 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR A 143 TYR~? -3.94 O1 EDO A 165s A 112 PHE A 145 PHE~? 8.08 C2 EDO A 162 A 140 ASN A 144 ASN~? -3.85 O1 EDO A 160s coo -6.29 44.15 17.65 -9.00 44.92 17.68 4.43 37.29 -29.96 6.41 39.04 -28.97 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -2.74 33.25 -25.54 -4.85 33.57 -23.76 coo -4.46 50.64 12.29 -5.69 49.89 13.85 0.74 31.64 -31.25 2.27 31.36 -32.72 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 2 hits 1o8s_p00 naa= 3 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS A 97 HIS.? 9.64 NA NA A 158 A 76 ASN A 155 ASN~? 13.88 NA NA A 158 A 81 ASP A 153 ASP~? 8.10 NA NA A 158 coo 4.09 43.69 67.89 2.45 42.40 68.10 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo 4.75 48.17 75.81 4.99 47.30 77.74 -19.90 35.20 -25.60 -20.04 36.55 -27.27 coo 0.57 50.41 73.18 0.46 48.28 73.56 -12.75 34.73 -26.28 -11.93 33.33 -27.60 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 1 hits 2c3x_p00 naa= 3 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 139 ARG~? -3.63 O1 EDO A 162s A 188 TYR A 126 TYR^? 6.32 O2 EDO A 162 A 190 SER A 124 SER~? -4.02 O2 EDO A 162s coo 37.69 7.64 13.51 38.82 8.84 16.11 7.88 34.40 -21.89 8.75 37.33 -21.46 coo 47.14 12.10 13.73 48.75 12.33 16.01 -0.56 32.51 -14.70 1.91 33.36 -13.69 coo 43.77 6.93 15.46 45.49 7.21 17.11 3.00 36.38 -17.33 4.86 35.21 -16.28 2p3i_p00 source 2p3i VP4 : 1 hits 2p3i_p00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 68 TYR^? 16.54 O2 EDO A 161 I 306 VAL A 79 VAL^? 13.29 O1 EDO A 159 I 308 VAL A 31 VAL.? 15.33 O1 EDO A 159 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.82 19.96 -3.61 4.36 19.12 -5.60 coo 16.43 30.18 9.35 15.05 30.67 11.01 9.56 20.61 3.61 11.70 21.19 3.58 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 68 TYR^? 16.54 O2 EDO A 161 I 306 VAL A 79 VAL^? 13.29 O1 EDO A 159 I 308 VAL A 77 VAL^? 6.40 O1 EDO A 159 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.78 23.48 -5.65 0.20 25.74 -7.17 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.82 19.96 -3.61 4.36 19.12 -5.60 coo 16.43 30.18 9.35 15.05 30.67 11.01 2.35 14.85 0.20 3.60 13.26 -0.64 1cqt_d00 source 1cqt GENE REGULATION/DNA : 2 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 128 PRO^? 12.91 O2 EDO A 162 A 272 LEU A 129 LEU~? 12.24 C1 EDO A 163 A 276 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -8.82 29.25 -15.88 -6.77 28.31 -15.89 coo 10.97 0.43 16.73 11.31 2.11 18.06 -5.50 23.42 -15.88 -4.09 24.09 -17.42 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -6.19 16.74 -10.46 -4.80 16.75 -13.27 1emh_d00 source 1emh HYDROLASE/DNA : 1 hits 1emh_d00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 55 LYS~? 4.25 C2 EDO A 163 D 25 THR A 108 THR.? 6.92 C1 EDO A 163 D 27 SER A 103 SER^? -4.23 C1 EDO A 163s coo 86.60 33.38 44.00 87.05 39.52 42.71 3.53 13.68 -16.08 1.21 12.50 -21.79 coo 81.20 31.58 48.03 79.23 32.24 47.54 0.06 16.88 -20.13 0.36 17.61 -18.07 coo 79.09 29.82 54.20 77.17 28.90 53.05 -0.52 20.98 -23.72 0.63 20.73 -25.82 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 1 hits 1mjo_d00 naa= 3 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 1 3 # 1 A 40 LYS A 52 LYS~? 14.37 O1 EDO A 163 A 41 LYS A 55 LYS~? 4.25 C2 EDO A 163 A 42 ILE A 106 ILE.? 9.06 O1 EDO A 163 coo 36.07 63.73 124.22 32.72 60.75 122.39 7.21 11.23 -18.19 10.21 5.87 -19.86 coo 38.49 66.12 125.64 35.69 66.71 131.25 3.53 13.68 -16.08 1.21 12.50 -21.79 coo 41.08 63.27 123.17 40.13 62.43 122.44 5.71 17.68 -17.86 5.40 18.07 -16.56 1pyi_d00 source 1pyi PROTEIN (PYRIMIDINE PATHWAY REGULATOR 1) : 1 hits 1pyi_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS A 76 LYS^? -2.76 O2 EDO A 159s A 564 VAL A 77 VAL^? 6.40 O1 EDO A 159 A 568 ARG A 78 ARG^? 11.61 O1 EDO A 159 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -0.73 12.68 0.50 -5.34 10.31 1.50 coo -9.25 78.14 55.31 -11.11 77.94 56.39 2.35 14.85 0.20 3.60 13.26 -0.64 coo -12.31 74.86 52.32 -13.99 74.91 54.92 3.40 20.49 2.82 1.01 22.14 3.95 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 1 hits 1r4i_d00 naa= 3 ULMN 4 2c7a_d00 RECEPTOR/DNA user 1 4 # 1 B 588 LYS A 76 LYS^? -2.76 O2 EDO A 159s B 589 VAL A 77 VAL^? 6.40 O1 EDO A 159 B 593 ARG A 78 ARG^? 11.61 O1 EDO A 159 B 637 ARG A 131 ARG~? 12.47 C2 EDO A 163 coo 15.04 42.21 35.01 15.60 47.38 33.10 -0.73 12.68 0.50 -5.34 10.31 1.50 coo 16.13 44.67 37.72 14.94 46.37 38.42 2.35 14.85 0.20 3.60 13.26 -0.64 coo 17.98 46.28 41.95 15.61 48.20 41.79 3.40 20.49 2.82 1.01 22.14 3.95 coo 20.10 48.80 24.99 18.70 47.38 22.62 -6.19 16.74 -10.46 -4.80 16.75 -13.27 2c7a_d00 source 2c7a RECEPTOR/DNA : 1 hits 2c7a_d00 naa= 4 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 98 SER.? 13.43 C2 EDO A 160 A 20 HIS A 97 HIS.? 9.64 NA NA A 158 A 22 LEU A 151 LEU~? 8.95 NA NA A 158 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -14.38 26.89 -29.15 -12.90 25.04 -29.74 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -15.78 31.45 -33.05 -15.49 32.94 -34.49 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -15.09 39.74 -30.59 -15.23 41.82 -29.79 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 1 hits 3gxq_d00 naa= 3 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 1 3 # 1 B 442 LYS A 76 LYS^? -2.76 O2 EDO A 159s B 443 VAL A 77 VAL^? 6.40 O1 EDO A 159 B 447 ARG A 78 ARG^? 11.61 O1 EDO A 159 coo -11.49 8.72 29.13 -11.20 3.78 25.16 -0.73 12.68 0.50 -5.34 10.31 1.50 coo -11.96 6.22 31.96 -10.74 4.61 32.81 2.35 14.85 0.20 3.60 13.26 -0.64 coo -14.58 4.58 36.41 -12.11 2.82 36.84 3.40 20.49 2.82 1.01 22.14 3.95 4hn5_d00 source 4hn5 TRANSCRIPTION/DNA : 1 hits 4hn5_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 62 HIS^? 12.35 O2 EDO A 159 A 208 ASP A 66 ASP.? 19.80 O2 EDO A 162 A 296 SER A 48 SER^? 16.22 C1 EDO A 161 coo 12.72 17.48 24.71 12.80 19.37 23.81 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo 18.47 29.19 29.68 19.30 29.17 27.75 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo 6.89 17.22 46.63 5.08 16.21 47.91 15.58 16.01 -11.89 15.60 16.65 -14.21 2odj_o00 source 2ODJ PORIN D : 1 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 62 HIS^? 12.35 O2 EDO A 159 B 208 ASP A 66 ASP.? 19.80 O2 EDO A 162 B 296 SER A 48 SER^? 16.22 C1 EDO A 161 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -5.47 17.51 -6.29 -6.49 15.78 -6.92 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -2.90 29.23 -2.02 -4.63 30.38 -2.07 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 15.58 16.01 -11.89 15.60 16.65 -14.21 2odj_o01 source 2ODJ PORIN D : 1 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 48 SER^? 16.22 C1 EDO A 161 A 166 PHE A 53 PHE~? 16.10 O1 EDO A 163 A 182 PHE A 57 PHE~? 14.39 O1 EDO A 159 coo -46.28 37.24 81.97 -44.96 39.32 82.40 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -36.62 39.62 84.60 -38.76 41.24 85.25 9.41 9.22 -13.84 10.03 6.56 -14.26 coo -36.55 45.66 79.22 -38.34 43.94 80.53 5.08 12.16 -9.44 6.74 10.10 -8.59 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 48 SER^? 16.22 C1 EDO A 161 B 166 PHE A 53 PHE~? 16.10 O1 EDO A 163 B 182 PHE A 57 PHE~? 14.39 O1 EDO A 159 coo -19.94 46.29 97.83 -22.38 46.56 97.60 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -29.59 43.40 95.66 -28.22 45.54 94.50 9.41 9.22 -13.84 10.03 6.56 -14.26 coo -32.72 50.15 98.46 -30.32 48.85 97.77 5.08 12.16 -9.44 6.74 10.10 -8.59 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 48 SER^? 16.22 C1 EDO A 161 C 166 PHE A 53 PHE~? 16.10 O1 EDO A 163 C 182 PHE A 57 PHE~? 14.39 O1 EDO A 159 coo -2.19 64.27 51.12 -3.34 62.10 50.60 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -11.14 61.91 46.89 -9.88 60.30 48.76 9.41 9.22 -13.84 10.03 6.56 -14.26 coo -7.71 55.92 42.70 -7.18 57.60 44.85 5.08 12.16 -9.44 6.74 10.10 -8.59 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 1 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 48 SER^? 16.22 C1 EDO A 161 D 166 PHE A 53 PHE~? 16.10 O1 EDO A 163 D 182 PHE A 57 PHE~? 14.39 O1 EDO A 159 coo -32.42 55.27 46.18 -30.51 54.94 47.67 15.58 16.01 -11.89 15.60 16.65 -14.21 coo -23.62 58.20 50.84 -23.76 56.14 48.96 9.41 9.22 -13.84 10.03 6.56 -14.26 coo -23.08 51.44 54.96 -24.43 52.71 52.88 5.08 12.16 -9.44 6.74 10.10 -8.59 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 98 SER.? 13.43 C2 EDO A 160 D 166 PHE A 91 PHE^? 3.94 C2 EDO A 160 D 182 PHE A 145 PHE~? 8.08 C2 EDO A 162 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.38 26.89 -29.15 -12.90 25.04 -29.74 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -2.83 27.70 -27.71 -2.24 29.94 -29.22 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -2.74 33.25 -25.54 -4.85 33.57 -23.76 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 98 SER.? 13.43 C2 EDO A 160 D 166 PHE A 149 PHE~? -6.17 NA NA A 158s D 182 PHE A 145 PHE~? 8.08 C2 EDO A 162 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.38 26.89 -29.15 -12.90 25.04 -29.74 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -9.07 38.04 -28.24 -11.22 39.46 -27.22 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -2.74 33.25 -25.54 -4.85 33.57 -23.76 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 124 SER~? -4.02 O2 EDO A 162s D 166 PHE A 145 PHE~? 8.08 C2 EDO A 162 D 182 PHE A 91 PHE^? 3.94 C2 EDO A 160 coo -32.42 55.27 46.18 -30.51 54.94 47.67 3.00 36.38 -17.33 4.86 35.21 -16.28 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -2.74 33.25 -25.54 -4.85 33.57 -23.76 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -2.83 27.70 -27.71 -2.24 29.94 -29.22 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 4 hits 2r11_o03 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 82 GLU.? 10.18 O2 EDO A 161 B 44 ASP A 41 ASP.? 9.35 C1 EDO A 161 B 50 THR A 43 THR^? 16.73 O2 EDO A 161 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 9.87 29.84 -8.60 11.75 29.89 -9.60 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 12.12 21.63 -14.87 12.29 22.09 -16.92 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 12.68 17.56 -8.98 14.04 19.15 -8.51 3hde_o01 source 3HDE LYSOZYME : 1 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 82 GLU.? 10.18 O2 EDO A 161 C 44 ASP A 41 ASP.? 9.35 C1 EDO A 161 C 50 THR A 43 THR^? 16.73 O2 EDO A 161 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 9.87 29.84 -8.60 11.75 29.89 -9.60 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 12.12 21.63 -14.87 12.29 22.09 -16.92 coo 25.48 4.87 1.60 23.90 4.95 0.15 12.68 17.56 -8.98 14.04 19.15 -8.51 3hde_o02 source 3HDE LYSOZYME : 1 hits 3hde_o02 naa= 3 ULMN 3 3uao_o07 PUTATIVE ISOCHORISMATASE user 1 3 # 1 H 28 VAL A 89 VAL^? 6.95 C1 EDO A 160 H 117 LYS A 136 LYS^? 4.23 O2 EDO A 161 H 150 CYH A 141 CYH~? -4.10 O1 EDO A 160s coo 45.82 27.58 23.40 45.30 28.87 21.66 3.71 25.27 -24.67 5.09 23.65 -24.07 coo 38.01 32.08 28.20 39.46 29.85 23.57 1.64 29.66 -17.31 7.12 31.17 -15.42 coo 41.19 29.62 18.76 39.21 28.51 20.32 3.42 30.61 -27.67 3.13 28.26 -26.13 3uao_o07 source 3UAO PUTATIVE ISOCHORISMATASE : 1 hits 3uao_o07 naa= 3 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 1 3 # 1 A 966 SER A 124 SER~? -4.02 O2 EDO A 162s A 967 ARG A 139 ARG~? -3.63 O1 EDO A 162s A 975 TYR A 126 TYR^? 6.32 O2 EDO A 162 coo 82.02 40.88 31.11 79.88 41.56 30.18 3.00 36.38 -17.33 4.86 35.21 -16.28 coo 78.94 44.79 33.75 77.86 47.56 32.82 7.88 34.40 -21.89 8.75 37.33 -21.46 coo 83.57 40.86 25.45 83.15 43.18 26.91 -0.56 32.51 -14.70 1.91 33.36 -13.69 4dqk_o00 source 4DQK BIFUNCTIONAL P-450/NADPH-P450 REDUCTASE : 1 hits 4dqk_o00 naa= 3